{"cells":[{"cell_type":"code","source":["dbutils.fs.ls(\"FileStore/tables/\")"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"e818f59e-0bb1-452f-88a5-4227b860c9d8"}},"outputs":[{"output_type":"display_data","metadata":{"application/vnd.databricks.v1+output":{"datasetInfos":[],"data":"Out[7]: [FileInfo(path='dbfs:/FileStore/tables/clinicaltrial_2019_csv.gz', name='clinicaltrial_2019_csv.gz', size=10060669, modificationTime=1650757928000),\n FileInfo(path='dbfs:/FileStore/tables/clinicaltrial_2020_csv.gz', name='clinicaltrial_2020_csv.gz', size=10981608, modificationTime=1650757932000),\n FileInfo(path='dbfs:/FileStore/tables/clinicaltrial_2021.csv', name='clinicaltrial_2021.csv', size=50359696, modificationTime=1652388947000),\n FileInfo(path='dbfs:/FileStore/tables/clinicaltrial_2021_csv.gz', name='clinicaltrial_2021_csv.gz', size=11921810, modificationTime=1650757976000),\n FileInfo(path='dbfs:/FileStore/tables/mesh-1.csv', name='mesh-1.csv', size=5295548, modificationTime=1652223661000),\n FileInfo(path='dbfs:/FileStore/tables/mesh.csv', name='mesh.csv', size=5295548, modificationTime=1651020967000),\n FileInfo(path='dbfs:/FileStore/tables/pharma-1.csv', name='pharma-1.csv', size=619715, modificationTime=1652223644000),\n FileInfo(path='dbfs:/FileStore/tables/pharma.csv', name='pharma.csv', size=619715, modificationTime=1651020946000),\n FileInfo(path='dbfs:/FileStore/tables/webpage.zip', name='webpage.zip', size=1582, modificationTime=1652209485000)]","removedWidgets":[],"addedWidgets":{},"metadata":{},"type":"ansi","arguments":{}}},"output_type":"display_data","data":{"text/plain":["Out[7]: [FileInfo(path='dbfs:/FileStore/tables/clinicaltrial_2019_csv.gz', name='clinicaltrial_2019_csv.gz', size=10060669, modificationTime=1650757928000),\n FileInfo(path='dbfs:/FileStore/tables/clinicaltrial_2020_csv.gz', name='clinicaltrial_2020_csv.gz', size=10981608, modificationTime=1650757932000),\n FileInfo(path='dbfs:/FileStore/tables/clinicaltrial_2021.csv', name='clinicaltrial_2021.csv', size=50359696, modificationTime=1652388947000),\n FileInfo(path='dbfs:/FileStore/tables/clinicaltrial_2021_csv.gz', name='clinicaltrial_2021_csv.gz', size=11921810, modificationTime=1650757976000),\n FileInfo(path='dbfs:/FileStore/tables/mesh-1.csv', name='mesh-1.csv', size=5295548, modificationTime=1652223661000),\n FileInfo(path='dbfs:/FileStore/tables/mesh.csv', name='mesh.csv', size=5295548, modificationTime=1651020967000),\n FileInfo(path='dbfs:/FileStore/tables/pharma-1.csv', name='pharma-1.csv', size=619715, modificationTime=1652223644000),\n FileInfo(path='dbfs:/FileStore/tables/pharma.csv', name='pharma.csv', size=619715, modificationTime=1651020946000),\n FileInfo(path='dbfs:/FileStore/tables/webpage.zip', name='webpage.zip', size=1582, modificationTime=1652209485000)]"]}}],"execution_count":0},{"cell_type":"code","source":["dbutils.fs.cp(\"FileStore/tables/clinicaltrial_2021_csv.gz\",\"file:/tmp/\")"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"7c3cfc04-f163-4343-a4da-44c92d70e39b"}},"outputs":[{"output_type":"display_data","metadata":{"application/vnd.databricks.v1+output":{"datasetInfos":[],"data":"Out[8]: True","removedWidgets":[],"addedWidgets":{},"metadata":{},"type":"ansi","arguments":{}}},"output_type":"display_data","data":{"text/plain":["Out[8]: True"]}}],"execution_count":0},{"cell_type":"code","source":["%sh\ngzip -d /tmp/clinicaltrial_2021_csv.gz"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"1c5bf23b-7e0c-4260-9c9c-8454bca08bd4"}},"outputs":[],"execution_count":0},{"cell_type":"code","source":["%sh\nls /tmp"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"0a23477f-d26f-44dc-93d1-40ebb3dd70ca"}},"outputs":[{"output_type":"display_data","metadata":{"application/vnd.databricks.v1+output":{"datasetInfos":[],"data":"Rserv\nRtmp1FxNq4\nchauffeur-daemon-params\nchauffeur-daemon.pid\nchauffeur-env.sh\nclinicaltrial_2021_csv\ncustom-spark.conf\ndriver-daemon-params\ndriver-daemon.pid\ndriver-env.sh\nhsperfdata_root\nipykernel-connection-ReplId-176df-0bcec-d4ba9-8.json\nipykernel-connection-ReplId-35414-b6389-cfdd5-6.json\nipykernel-connection-ReplId-3d793-35f85-795ee-9.json\nipykernel-connection-ReplId-3e0c7-444ab-2638d-c.json\nsystemd-private-b2377b96cd7d4635bc7ed475b33154f7-apache2.service-iqBeUh\nsystemd-private-b2377b96cd7d4635bc7ed475b33154f7-ntp.service-3QIaWe\nsystemd-private-b2377b96cd7d4635bc7ed475b33154f7-systemd-logind.service-5Othvg\nsystemd-private-b2377b96cd7d4635bc7ed475b33154f7-systemd-resolved.service-tUGo2f\ntmp.3EaIBO8h3n\n","removedWidgets":[],"addedWidgets":{},"metadata":{},"type":"ansi","arguments":{}}},"output_type":"display_data","data":{"text/plain":["Rserv\nRtmp1FxNq4\nchauffeur-daemon-params\nchauffeur-daemon.pid\nchauffeur-env.sh\nclinicaltrial_2021_csv\ncustom-spark.conf\ndriver-daemon-params\ndriver-daemon.pid\ndriver-env.sh\nhsperfdata_root\nipykernel-connection-ReplId-176df-0bcec-d4ba9-8.json\nipykernel-connection-ReplId-35414-b6389-cfdd5-6.json\nipykernel-connection-ReplId-3d793-35f85-795ee-9.json\nipykernel-connection-ReplId-3e0c7-444ab-2638d-c.json\nsystemd-private-b2377b96cd7d4635bc7ed475b33154f7-apache2.service-iqBeUh\nsystemd-private-b2377b96cd7d4635bc7ed475b33154f7-ntp.service-3QIaWe\nsystemd-private-b2377b96cd7d4635bc7ed475b33154f7-systemd-logind.service-5Othvg\nsystemd-private-b2377b96cd7d4635bc7ed475b33154f7-systemd-resolved.service-tUGo2f\ntmp.3EaIBO8h3n\n"]}}],"execution_count":0},{"cell_type":"code","source":["mv /tmp/clinicaltrial_2021_csv /tmp/clinicaltrial_2021.csv"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"04153de8-fbc1-4c86-9c47-2e9d2a4db6d1"}},"outputs":[],"execution_count":0},{"cell_type":"code","source":["dbutils.fs.mv(\"file:/tmp/clinicaltrial_2021.csv\",\"/FileStore/tables/\",True)"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"156e8ecf-45c2-43de-aa2d-e9ce7bc964da"}},"outputs":[{"output_type":"display_data","metadata":{"application/vnd.databricks.v1+output":{"datasetInfos":[],"data":"Out[12]: True","removedWidgets":[],"addedWidgets":{},"metadata":{},"type":"ansi","arguments":{}}},"output_type":"display_data","data":{"text/plain":["Out[12]: True"]}}],"execution_count":0},{"cell_type":"code","source":["dbutils.fs.ls(\"/FileStore/tables/\")"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"a8ab78a1-9e84-41d3-8c69-63007e9008a7"}},"outputs":[{"output_type":"display_data","metadata":{"application/vnd.databricks.v1+output":{"datasetInfos":[],"data":"Out[13]: [FileInfo(path='dbfs:/FileStore/tables/clinicaltrial_2019_csv.gz', name='clinicaltrial_2019_csv.gz', size=10060669, modificationTime=1650757928000),\n FileInfo(path='dbfs:/FileStore/tables/clinicaltrial_2020_csv.gz', name='clinicaltrial_2020_csv.gz', size=10981608, modificationTime=1650757932000),\n FileInfo(path='dbfs:/FileStore/tables/clinicaltrial_2021.csv', name='clinicaltrial_2021.csv', size=50359696, modificationTime=1652388968000),\n FileInfo(path='dbfs:/FileStore/tables/clinicaltrial_2021_csv.gz', name='clinicaltrial_2021_csv.gz', size=11921810, modificationTime=1650757976000),\n FileInfo(path='dbfs:/FileStore/tables/mesh-1.csv', name='mesh-1.csv', size=5295548, modificationTime=1652223661000),\n FileInfo(path='dbfs:/FileStore/tables/mesh.csv', name='mesh.csv', size=5295548, modificationTime=1651020967000),\n FileInfo(path='dbfs:/FileStore/tables/pharma-1.csv', name='pharma-1.csv', size=619715, modificationTime=1652223644000),\n FileInfo(path='dbfs:/FileStore/tables/pharma.csv', name='pharma.csv', size=619715, modificationTime=1651020946000),\n FileInfo(path='dbfs:/FileStore/tables/webpage.zip', name='webpage.zip', size=1582, modificationTime=1652209485000)]","removedWidgets":[],"addedWidgets":{},"metadata":{},"type":"ansi","arguments":{}}},"output_type":"display_data","data":{"text/plain":["Out[13]: [FileInfo(path='dbfs:/FileStore/tables/clinicaltrial_2019_csv.gz', name='clinicaltrial_2019_csv.gz', size=10060669, modificationTime=1650757928000),\n FileInfo(path='dbfs:/FileStore/tables/clinicaltrial_2020_csv.gz', name='clinicaltrial_2020_csv.gz', size=10981608, modificationTime=1650757932000),\n FileInfo(path='dbfs:/FileStore/tables/clinicaltrial_2021.csv', name='clinicaltrial_2021.csv', size=50359696, modificationTime=1652388968000),\n FileInfo(path='dbfs:/FileStore/tables/clinicaltrial_2021_csv.gz', name='clinicaltrial_2021_csv.gz', size=11921810, modificationTime=1650757976000),\n FileInfo(path='dbfs:/FileStore/tables/mesh-1.csv', name='mesh-1.csv', size=5295548, modificationTime=1652223661000),\n FileInfo(path='dbfs:/FileStore/tables/mesh.csv', name='mesh.csv', size=5295548, modificationTime=1651020967000),\n FileInfo(path='dbfs:/FileStore/tables/pharma-1.csv', name='pharma-1.csv', size=619715, modificationTime=1652223644000),\n FileInfo(path='dbfs:/FileStore/tables/pharma.csv', name='pharma.csv', size=619715, modificationTime=1651020946000),\n FileInfo(path='dbfs:/FileStore/tables/webpage.zip', name='webpage.zip', size=1582, modificationTime=1652209485000)]"]}}],"execution_count":0},{"cell_type":"code","source":["clinicaltrial_2021=spark.read.csv(\"/FileStore/tables/clinicaltrial_2021.csv\",sep=\"|\",header=True)\nclinicaltrial_2021.take(10)"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"405a7498-0b1f-4a9c-b8cb-8155de710a0b"}},"outputs":[{"output_type":"display_data","metadata":{"application/vnd.databricks.v1+output":{"datasetInfos":[],"data":"Out[14]: [Row(Id='NCT02758028', Sponsor='The University of Hong Kong', Status='Recruiting', Start='Aug 2005', Completion='Nov 2021', Type='Interventional', Submission='Apr 2016', Conditions=None, Interventions=None),\n Row(Id='NCT02751957', Sponsor='Duke University', Status='Completed', Start='Jul 2016', Completion='Jul 2020', Type='Interventional', Submission='Apr 2016', Conditions='Autistic Disorder,Autism Spectrum Disorder', Interventions=None),\n Row(Id='NCT02758483', Sponsor='Universidade Federal do Rio de Janeiro', Status='Completed', Start='Mar 2017', Completion='Jan 2018', Type='Interventional', Submission='Apr 2016', Conditions='Diabetes Mellitus', Interventions=None),\n Row(Id='NCT02759848', Sponsor='Istanbul Medeniyet University', Status='Completed', Start='Jan 2012', Completion='Dec 2014', Type='Observational', Submission='May 2016', Conditions='Tuberculosis,Lung Diseases,Pulmonary Disease', Interventions=None),\n Row(Id='NCT02758860', Sponsor='University of Roma La Sapienza', Status='Active, not recruiting', Start='Jun 2016', Completion='Sep 2020', Type='Observational [Patient Registry]', Submission='Apr 2016', Conditions='Diverticular Diseases,Diverticulum,Diverticulosis', Interventions=None),\n Row(Id='NCT02757209', Sponsor='Consorzio Futuro in Ricerca', Status='Completed', Start='Apr 2016', Completion='Jan 2018', Type='Interventional', Submission='Apr 2016', Conditions='Asthma', Interventions='Fluticasone,Xhance,Budesonide,Formoterol Fumarate,Salmeterol Xinafoate'),\n Row(Id='NCT02752438', Sponsor='Ankara University', Status='Unknown status', Start='May 2016', Completion='Jul 2017', Type='Observational [Patient Registry]', Submission='Apr 2016', Conditions='Hypoventilation', Interventions=None),\n Row(Id='NCT02753543', Sponsor='Ruijin Hospital', Status='Unknown status', Start='Nov 2015', Completion='Nov 2019', Type='Interventional', Submission='Apr 2016', Conditions='Lymphoma', Interventions=None),\n Row(Id='NCT02757508', Sponsor='Washington University School of Medicine', Status='Completed', Start='Mar 2016', Completion='Jul 2017', Type='Interventional', Submission='Apr 2016', Conditions=None, Interventions='Vitamins'),\n Row(Id='NCT02753530', Sponsor='Orphazyme', Status='Completed', Start='Aug 2017', Completion='Jan 2021', Type='Interventional', Submission='Apr 2016', Conditions='Myositis', Interventions=None)]","removedWidgets":[],"addedWidgets":{},"metadata":{},"type":"ansi","arguments":{}}},"output_type":"display_data","data":{"text/plain":["Out[14]: [Row(Id='NCT02758028', Sponsor='The University of Hong Kong', Status='Recruiting', Start='Aug 2005', Completion='Nov 2021', Type='Interventional', Submission='Apr 2016', Conditions=None, Interventions=None),\n Row(Id='NCT02751957', Sponsor='Duke University', Status='Completed', Start='Jul 2016', Completion='Jul 2020', Type='Interventional', Submission='Apr 2016', Conditions='Autistic Disorder,Autism Spectrum Disorder', Interventions=None),\n Row(Id='NCT02758483', Sponsor='Universidade Federal do Rio de Janeiro', Status='Completed', Start='Mar 2017', Completion='Jan 2018', Type='Interventional', Submission='Apr 2016', Conditions='Diabetes Mellitus', Interventions=None),\n Row(Id='NCT02759848', Sponsor='Istanbul Medeniyet University', Status='Completed', Start='Jan 2012', Completion='Dec 2014', Type='Observational', Submission='May 2016', Conditions='Tuberculosis,Lung Diseases,Pulmonary Disease', Interventions=None),\n Row(Id='NCT02758860', Sponsor='University of Roma La Sapienza', Status='Active, not recruiting', Start='Jun 2016', Completion='Sep 2020', Type='Observational [Patient Registry]', Submission='Apr 2016', Conditions='Diverticular Diseases,Diverticulum,Diverticulosis', Interventions=None),\n Row(Id='NCT02757209', Sponsor='Consorzio Futuro in Ricerca', Status='Completed', Start='Apr 2016', Completion='Jan 2018', Type='Interventional', Submission='Apr 2016', Conditions='Asthma', Interventions='Fluticasone,Xhance,Budesonide,Formoterol Fumarate,Salmeterol Xinafoate'),\n Row(Id='NCT02752438', Sponsor='Ankara University', Status='Unknown status', Start='May 2016', Completion='Jul 2017', Type='Observational [Patient Registry]', Submission='Apr 2016', Conditions='Hypoventilation', Interventions=None),\n Row(Id='NCT02753543', Sponsor='Ruijin Hospital', Status='Unknown status', Start='Nov 2015', Completion='Nov 2019', Type='Interventional', Submission='Apr 2016', Conditions='Lymphoma', Interventions=None),\n Row(Id='NCT02757508', Sponsor='Washington University School of Medicine', Status='Completed', Start='Mar 2016', Completion='Jul 2017', Type='Interventional', Submission='Apr 2016', Conditions=None, Interventions='Vitamins'),\n Row(Id='NCT02753530', Sponsor='Orphazyme', Status='Completed', Start='Aug 2017', Completion='Jan 2021', Type='Interventional', Submission='Apr 2016', Conditions='Myositis', Interventions=None)]"]}}],"execution_count":0},{"cell_type":"code","source":["#Problem1\nclinicaltrial_2021.count()"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"1a7088c7-1043-4a79-9017-6bc7ac14793b"}},"outputs":[{"output_type":"display_data","metadata":{"application/vnd.databricks.v1+output":{"datasetInfos":[],"data":"Out[15]: 387261","removedWidgets":[],"addedWidgets":{},"metadata":{},"type":"ansi","arguments":{}}},"output_type":"display_data","data":{"text/plain":["Out[15]: 387261"]}}],"execution_count":0},{"cell_type":"code","source":["#Problem2\nfrom pyspark.sql.functions import desc\n#Frequency of Type of treatment\ncltrial_count_df=clinicaltrial_2021.groupBy('Type').count().sort(desc(\"count\"))\ncltrial_count_df.show()"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"a74f3c10-81d8-4664-9a63-4dcee76044d3"}},"outputs":[{"output_type":"display_data","metadata":{"application/vnd.databricks.v1+output":{"datasetInfos":[],"data":"+--------------------+------+\n|                Type| count|\n+--------------------+------+\n|      Interventional|301472|\n|       Observational| 77540|\n|Observational [Pa...|  8180|\n|     Expanded Access|    69|\n+--------------------+------+\n\n","removedWidgets":[],"addedWidgets":{},"metadata":{},"type":"ansi","arguments":{}}},"output_type":"display_data","data":{"text/plain":["+--------------------+------+\n|                Type| count|\n+--------------------+------+\n|      Interventional|301472|\n|       Observational| 77540|\n|Observational [Pa...|  8180|\n|     Expanded Access|    69|\n+--------------------+------+\n\n"]}}],"execution_count":0},{"cell_type":"code","source":["#Problem3\nfrom pyspark.sql.functions import explode\nfrom pyspark.sql.functions import split\nfrom pyspark.sql.functions import desc\nclinicaltrial_2021a=clinicaltrial_2021.select(\"Conditions\",explode(split(\"Conditions\",\",\"))).dropna()\n#Frequency of top 5 Conditions\ncltrial_countcond_df=clinicaltrial_2021a.groupBy(\"col\").count().sort(desc(\"count\"))\ncltrial_countcond_df.show(5)"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"fe92a080-583f-451e-92ab-4213fb14f5a4"}},"outputs":[{"output_type":"display_data","metadata":{"application/vnd.databricks.v1+output":{"datasetInfos":[],"data":"+-----------------+-----+\n|              col|count|\n+-----------------+-----+\n|        Carcinoma|13389|\n|Diabetes Mellitus|11080|\n|        Neoplasms| 9371|\n| Breast Neoplasms| 8640|\n|         Syndrome| 8032|\n+-----------------+-----+\nonly showing top 5 rows\n\n","removedWidgets":[],"addedWidgets":{},"metadata":{},"type":"ansi","arguments":{}}},"output_type":"display_data","data":{"text/plain":["+-----------------+-----+\n|              col|count|\n+-----------------+-----+\n|        Carcinoma|13389|\n|Diabetes Mellitus|11080|\n|        Neoplasms| 9371|\n| Breast Neoplasms| 8640|\n|         Syndrome| 8032|\n+-----------------+-----+\nonly showing top 5 rows\n\n"]}}],"execution_count":0},{"cell_type":"code","source":["#Problem4\nfrom pyspark.sql.functions import col\nmesh=spark.read.csv(\"/FileStore/tables/mesh.csv\",sep=',',header=True)\nmesh.show()\ncltrial_mesh_df=clinicaltrial_2021.select(['Id','Conditions']).withColumn('Conditions',explode(split('Conditions',',')))\ncltrial_mesh_df=mesh.join(cltrial_mesh_df,cltrial_mesh_df.Conditions==mesh.term,how='inner')\ncltrial_mesh_df.show(10)\ncltrial_mesh_df1=cltrial_mesh_df.withColumn('Tree', col('tree').substr(1,3)).groupBy('Tree').count()\n#Intervention frequency top 10 dataframe\ncltrial_meshsol_df=cltrial_mesh_df1.orderBy('count',ascending=False)\ncltrial_meshsol_df.show(10)"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"544db72f-d20a-4068-bd03-10f9a2ead7e4"}},"outputs":[{"output_type":"display_data","metadata":{"application/vnd.databricks.v1+output":{"datasetInfos":[],"data":"+--------------------+--------------------+\n|                term|                tree|\n+--------------------+--------------------+\n|          Calcimycin| D03.633.100.221.173|\n|             A-23187| D03.633.100.221.173|\n|             Temefos| D02.705.400.625.800|\n|             Temefos| D02.705.539.345.800|\n|             Temefos| D02.886.300.692.800|\n|               Abate| D02.705.400.625.800|\n|               Abate| D02.705.539.345.800|\n|               Abate| D02.886.300.692.800|\n|               Difos| D02.705.400.625.800|\n|               Difos| D02.705.539.345.800|\n|               Difos| D02.886.300.692.800|\n|           Abattoirs|J01.576.423.200.7...|\n|           Abattoirs|         J03.540.020|\n|Abbreviations as ...|L01.559.598.400.5...|\n|   Acronyms as Topic|L01.559.598.400.5...|\n|             Abdomen|         A01.923.047|\n|      Abdomen, Acute|C23.888.592.612.0...|\n|      Abdomen, Acute| C23.888.821.030.249|\n|  Abdominal Injuries|             C26.017|\n| Abdominal Neoplasms|         C04.588.033|\n+--------------------+--------------------+\nonly showing top 20 rows\n\n+--------------------+--------------------+-----------+--------------------+\n|                term|                tree|         Id|          Conditions|\n+--------------------+--------------------+-----------+--------------------+\n|   Autistic Disorder| F03.625.164.113.500|NCT02751957|   Autistic Disorder|\n|Autism Spectrum D...|     F03.625.164.113|NCT02751957|Autism Spectrum D...|\n|   Diabetes Mellitus|             C19.246|NCT02758483|   Diabetes Mellitus|\n|   Diabetes Mellitus|     C18.452.394.750|NCT02758483|   Diabetes Mellitus|\n|        Tuberculosis|C01.150.252.410.0...|NCT02759848|        Tuberculosis|\n|       Lung Diseases|             C08.381|NCT02759848|       Lung Diseases|\n|Diverticular Dise...|     C06.405.205.282|NCT02758860|Diverticular Dise...|\n|        Diverticulum|         C23.300.415|NCT02758860|        Diverticulum|\n|        Diverticulum| C06.405.205.282.750|NCT02758860|        Diverticulum|\n|      Diverticulosis|         C23.300.415|NCT02758860|      Diverticulosis|\n+--------------------+--------------------+-----------+--------------------+\nonly showing top 10 rows\n\n+----+------+\n|Tree| count|\n+----+------+\n| C04|143994|\n| C23|136079|\n| C01|106674|\n| C14| 94523|\n| C10| 92310|\n| C06| 85646|\n| C08| 70720|\n| C13| 42599|\n| C18| 41276|\n| C12| 40161|\n+----+------+\nonly showing top 10 rows\n\n","removedWidgets":[],"addedWidgets":{},"metadata":{},"type":"ansi","arguments":{}}},"output_type":"display_data","data":{"text/plain":["+--------------------+--------------------+\n|                term|                tree|\n+--------------------+--------------------+\n|          Calcimycin| D03.633.100.221.173|\n|             A-23187| D03.633.100.221.173|\n|             Temefos| D02.705.400.625.800|\n|             Temefos| D02.705.539.345.800|\n|             Temefos| D02.886.300.692.800|\n|               Abate| D02.705.400.625.800|\n|               Abate| D02.705.539.345.800|\n|               Abate| D02.886.300.692.800|\n|               Difos| D02.705.400.625.800|\n|               Difos| D02.705.539.345.800|\n|               Difos| D02.886.300.692.800|\n|           Abattoirs|J01.576.423.200.7...|\n|           Abattoirs|         J03.540.020|\n|Abbreviations as ...|L01.559.598.400.5...|\n|   Acronyms as Topic|L01.559.598.400.5...|\n|             Abdomen|         A01.923.047|\n|      Abdomen, Acute|C23.888.592.612.0...|\n|      Abdomen, Acute| C23.888.821.030.249|\n|  Abdominal Injuries|             C26.017|\n| Abdominal Neoplasms|         C04.588.033|\n+--------------------+--------------------+\nonly showing top 20 rows\n\n+--------------------+--------------------+-----------+--------------------+\n|                term|                tree|         Id|          Conditions|\n+--------------------+--------------------+-----------+--------------------+\n|   Autistic Disorder| F03.625.164.113.500|NCT02751957|   Autistic Disorder|\n|Autism Spectrum D...|     F03.625.164.113|NCT02751957|Autism Spectrum D...|\n|   Diabetes Mellitus|             C19.246|NCT02758483|   Diabetes Mellitus|\n|   Diabetes Mellitus|     C18.452.394.750|NCT02758483|   Diabetes Mellitus|\n|        Tuberculosis|C01.150.252.410.0...|NCT02759848|        Tuberculosis|\n|       Lung Diseases|             C08.381|NCT02759848|       Lung Diseases|\n|Diverticular Dise...|     C06.405.205.282|NCT02758860|Diverticular Dise...|\n|        Diverticulum|         C23.300.415|NCT02758860|        Diverticulum|\n|        Diverticulum| C06.405.205.282.750|NCT02758860|        Diverticulum|\n|      Diverticulosis|         C23.300.415|NCT02758860|      Diverticulosis|\n+--------------------+--------------------+-----------+--------------------+\nonly showing top 10 rows\n\n+----+------+\n|Tree| count|\n+----+------+\n| C04|143994|\n| C23|136079|\n| C01|106674|\n| C14| 94523|\n| C10| 92310|\n| C06| 85646|\n| C08| 70720|\n| C13| 42599|\n| C18| 41276|\n| C12| 40161|\n+----+------+\nonly showing top 10 rows\n\n"]}}],"execution_count":0},{"cell_type":"code","source":["#Problem5\npharma=spark.read.csv(\"/FileStore/tables/pharma.csv\",sep=',',header=True)\npharma.show()\ncltrial_pharma_df1=pharma.select(['Parent_Company'])\ncltrial_pharma_df1.show()\ncltrial_pharma_df2=clinicaltrial_2021.select(['Sponsor'])\ncltrial_pharma_df2.show()\nfrom pyspark.sql.functions import col\n\ncltrial_pharm_df3=cltrial_pharma_df2.join(cltrial_pharma_df1,cltrial_pharma_df1.Parent_Company==cltrial_pharma_df2.Sponsor,'leftanti')\ncltrial_pharm_df3.show()\n#Frequency of Sponsors without Private Companies\ncltrial_pharma_df4=cltrial_pharm_df3.groupBy('Sponsor').count().orderBy('count',ascending=False)\ncltrial_pharma_df4.show(10)"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"48510aa3-601b-402b-b998-d09c79aa062c"}},"outputs":[{"output_type":"display_data","metadata":{"application/vnd.databricks.v1+output":{"datasetInfos":[],"data":"+--------------------+--------------------+--------------+------------------------+---------------------------------------------------------+------------+------------+--------------------+--------------------+--------------------+--------------------+-------------------+-------------+--------------------+------------------+---------------------+-----+---------------+-----------------------------+------------------+--------------+------------+--------------------+-----+----------+--------------------+--------------------+------------------+-------------------+---------------------------+------------------------+---------------------------+--------------------+--------------------+\n|             Company|      Parent_Company|Penalty_Amount|Subtraction_From_Penalty|Penalty_Amount_Adjusted_For_Eliminating_Multiple_Counting|Penalty_Year|Penalty_Date|       Offense_Group|     Primary_Offense|   Secondary_Offense|         Description|Level_of_Government|  Action_Type|              Agency|    Civil/Criminal|Prosecution_Agreement|Court|        Case_ID|Private_Litigation_Case_Title|Lawsuit_Resolution|Facility_State|        City|             Address|  Zip|NAICS_Code|   NAICS_Translation|HQ_Country_of_Parent|HQ_State_of_Parent|Ownership_Structure|Parent_Company_Stock_Ticker|Major_Industry_of_Parent|Specific_Industry_of_Parent|         Info_Source|               Notes|\n+--------------------+--------------------+--------------+------------------------+---------------------------------------------------------+------------+------------+--------------------+--------------------+--------------------+--------------------+-------------------+-------------+--------------------+------------------+---------------------+-----+---------------+-----------------------------+------------------+--------------+------------+--------------------+-----+----------+--------------------+--------------------+------------------+-------------------+---------------------------+------------------------+---------------------------+--------------------+--------------------+\n| Abbott Laboratories| Abbott Laboratories|    $5,475,000|                      $0|                                               $5,475,000|        2013|    20131227|government-contra...|False Claims Act ...|kickbacks and bri...|Abbott Laboratori...|            federal|agency action|Justice Departmen...|             civil|                 null| null|           null|                         null|              null|          null|        null|                null| null|      null|                null|                 USA|          Illinois|    publicly traded|                        ABT|         pharmaceuticals|            pharmaceuticals|https://www.justi...|                null|\n|Abbott Laboratori...|              AbbVie|$1,500,000,000|                      $0|                                           $1,500,000,000|        2012|    20120507|healthcare-relate...|off-label or unap...|                null|Global Health Car...|            federal|agency action|Food and Drug Adm...|civil and criminal|                 null| null|           null|                         null|              null|          null|        null|                null| null|      null|                null|                 USA|          Illinois|    publicly traded|                       ABBV|         pharmaceuticals|            pharmaceuticals|http://www.justic...|                null|\n|Abbott Laboratori...|              AbbVie|  $126,500,000|                      $0|                                             $126,500,000|        2010|    20101207|government-contra...|False Claims Act ...|                null|Abbott Laboratori...|            federal|agency action|Justice Departmen...|             civil|                 null| null|           null|                         null|              null|          null|        null|                null| null|      null|                null|                 USA|          Illinois|    publicly traded|                       ABBV|         pharmaceuticals|            pharmaceuticals|https://www.justi...|                null|\n|Abbott Laboratori...| Abbott Laboratories|       $49,045|                      $0|                                                  $49,045|        2009|    20090305|employment-relate...|wage and hour vio...|Fair Labor Standa...|                null|            federal|agency action|Labor Department ...|             civil|                 null| null|        1527129|                         null|              null|   Puerto Rico|    San Juan|                null| null|    423450|423450: Medical, ...|                 USA|          Illinois|    publicly traded|                        ABT|         pharmaceuticals|            pharmaceuticals|March 7, 2017 dow...|Date and year are...|\n|      Acclarent Inc.|   Johnson & Johnson|   $18,000,000|                      $0|                                              $18,000,000|        2016|    20160722|government-contra...|False Claims Act ...|                null|California-based ...|            federal|agency action|Justice Departmen...|             civil|                 null| null|           null|                         null|              null|          null|        null|                null| null|      null|                null|                 USA|        New Jersey|    publicly traded|                        JNJ|         pharmaceuticals|            pharmaceuticals|https://www.justi...|                null|\n|Advanced Medical ...| Abbott Laboratories|       $16,800|                      $0|                                                  $16,800|        2004|    20040412|employment-relate...|labor relations v...|                null|back pay award in...|            federal|agency action|National Labor Re...|             civil|                 null| null|21-CA-36104-001|                         null|              null|    California|      Irvine|                null|92606|    333314|333314: Optical I...|                 USA|          Illinois|    publicly traded|                        ABT|         pharmaceuticals|            pharmaceuticals|Extracted from an...|                null|\n|Advanced Neuromod...| Abbott Laboratories|    $2,950,000|                      $0|                                               $2,950,000|        2007|    20070702|healthcare-relate...|HHS civil monetar...|kickbacks and bri...|The HHS Inspector...|            federal|agency action|Health & Human Se...|             civil|                 null| null|           null|                         null|              null|          null|        null|                null| null|      null|                null|                 USA|          Illinois|    publicly traded|                        ABT|         pharmaceuticals|            pharmaceuticals|https://oig.hhs.g...|                null|\n|Advanced Steriliz...|   Johnson & Johnson|      $136,800|                      $0|                                                 $136,800|        2014|    20140520|environment-relat...|environmental vio...|                null|The U.S. Environm...|            federal|agency action|Environmental Pro...|             civil|                 null| null|           null|                         null|              null|    California|      Irvine|                null| null|      null|                null|                 USA|        New Jersey|    publicly traded|                        JNJ|         pharmaceuticals|            pharmaceuticals|https://archive.e...|                null|\n|Advanced Steriliz...|   Johnson & Johnson|    $1,200,000|                      $0|                                               $1,200,000|        2013|    20131204|safety-related of...|drug or medical e...|                null|Settlement of a c...|            federal|agency action|Food and Drug Adm...|             civil|                 null| null|           null|                         null|              null|    California|      Irvine|                null| null|      null|                null|                 USA|        New Jersey|    publicly traded|                        JNJ|         pharmaceuticals|            pharmaceuticals|http://www.fda.go...|                null|\n|Alere San Diego Inc.| Abbott Laboratories|       $10,572|                      $0|                                                  $10,572|        2017|    20170309|employment-relate...|wage and hour vio...|Fair Labor Standa...|                null|            federal|agency action|Labor Department ...|             civil|                 null| null|        1813371|                         null|              null|    California|      Pomona|828 Towne Center Dr.|91767|      null|                null|                 USA|          Illinois|    publicly traded|                        ABT|         pharmaceuticals|            pharmaceuticals|July 23, 2017 dow...|Date and year are...|\n|       Allergan Inc.|              AbbVie|  $600,000,000|                      $0|                                             $600,000,000|        2010|    20100901|healthcare-relate...|off-label or unap...|                null|American pharmace...|            federal|agency action|Food and Drug Adm...|civil and criminal|                 null| null|           null|                         null|              null|          null|        null|                null| null|      null|                null|                 USA|          Illinois|    publicly traded|                       ABBV|         pharmaceuticals|            pharmaceuticals|http://www.justic...|                null|\n|       Allergan Inc.|              AbbVie|   $15,000,000|                      $0|                                              $15,000,000|        2017|    20170117|  financial offenses|investor protecti...|                null|Allergan Inc. adm...|            federal|agency action|Securities and Ex...|             civil|                 null| null|           null|                         null|              null|          null|        null|                null| null|      null|                null|                 USA|          Illinois|    publicly traded|                       ABBV|         pharmaceuticals|            pharmaceuticals|https://www.sec.g...|                null|\n|       Alpharma Inc.|              Pfizer|   $42,500,000|                      $0|                                              $42,500,000|        2010|    20100316|government-contra...|False Claims Act ...|kickbacks and bri...|Alpharma Inc. agr...|            federal|agency action|Justice Departmen...|             civil|                 null| null|           null|                         null|              null|          null|        null|                null| null|      null|                null|                 USA|          New York|    publicly traded|                        PFE|         pharmaceuticals|            pharmaceuticals|https://www.justi...|                null|\n|      Alpharma, Inc.|              Pfizer|    $2,500,000|                      $0|                                               $2,500,000|        2004|    20040812|competition-relat...|price-fixing or a...|consumer protecti...|Generic drug manu...|            federal|agency action|Federal Trade Com...|             civil|                 null| null|           null|                         null|              null|          null|        null|                null| null|      null|                null|                 USA|          New York|    publicly traded|                        PFE|         pharmaceuticals|            pharmaceuticals|https://www.ftc.g...|                null|\n|American Pharmace...|Bristol-Myers Squibb|      $160,203|                      $0|                                                 $160,203|        2004|    20041226|employment-relate...|wage and hour vio...|Fair Labor Standa...|                null|            federal|agency action|Labor Department ...|             civil|                 null| null|        1379241|                         null|              null|      New York|Grand Island|                null|14072|     32541|32541: Pharmaceut...|                 USA|          New York|    publicly traded|                        BMY|         pharmaceuticals|            pharmaceuticals|March 7, 2017 dow...|Date and year are...|\n|          Amgen Inc.|               Amgen|  $762,000,000|                      $0|                                             $762,000,000|        2012|    20121219|healthcare-relate...|off-label or unap...|                null|U.S. District Jud...|            federal|agency action|Food and Drug Adm...|civil and criminal|                 null| null|           null|                         null|              null|          null|        null|                null| null|      null|                null|                 USA|        California|    publicly traded|                       AMGN|         pharmaceuticals|            pharmaceuticals|http://www.justic...|                null|\n|          Amgen Inc.|               Amgen|   $24,900,000|                      $0|                                              $24,900,000|        2013|    20130416|government-contra...|False Claims Act ...|kickbacks and bri...|\"Amgen Inc. agree...|            federal|agency action|Justice Departmen...|             civil|                 null| null|           null|                         null|              null|          null|        null|                null| null|      null|                null|                 USA|        California|    publicly traded|                       AMGN|         pharmaceuticals|            pharmaceuticals|https://www.justi...|                null|\n|         Amgen, Inc.|               Amgen|       $40,000|                      $0|                                                  $40,000|        2011|    20110302|employment-relate...|labor relations v...|                null|back pay award in...|            federal|agency action|National Labor Re...|             civil|                 null| null|14-CA-30273-001|                         null|              null|      Missouri|   St. Louis|                null|63130|    541720|541720: Research ...|                 USA|        California|    publicly traded|                       AMGN|         pharmaceuticals|            pharmaceuticals|Extracted from an...|                null|\n|Amneal Pharmaceut...|Amneal Pharmaceut...|       $99,000|                      $0|                                                  $99,000|        2015|    20150930|employment-relate...|employment discri...|                null|                null|            federal|agency action|Office of Federal...|             civil|                 null| null|           null|                         null|              null|          null|        null|                null| null|      null|                null|                 USA|        New Jersey|    publicly traded|                       AMRX|         pharmaceuticals|            pharmaceuticals|https://www.dol.g...|                null|\n|Astellas Pharma U...|     Astellas Pharma|    $7,300,000|                      $0|                                               $7,300,000|        2014|    20140416|government-contra...|False Claims Act ...|off-label or unap...|Astellas Pharma U...|            federal|agency action|Justice Departmen...|             civil|                 null| null|           null|                         null|              null|          null|        null|                null| null|      null|                null|               Japan|              null|    publicly traded|                       null|         pharmaceuticals|            pharmaceuticals|https://www.justi...|                null|\n+--------------------+--------------------+--------------+------------------------+---------------------------------------------------------+------------+------------+--------------------+--------------------+--------------------+--------------------+-------------------+-------------+--------------------+------------------+---------------------+-----+---------------+-----------------------------+------------------+--------------+------------+--------------------+-----+----------+--------------------+--------------------+------------------+-------------------+---------------------------+------------------------+---------------------------+--------------------+--------------------+\nonly showing top 20 rows\n\n+--------------------+\n|      Parent_Company|\n+--------------------+\n| Abbott Laboratories|\n|              AbbVie|\n|              AbbVie|\n| Abbott Laboratories|\n|   Johnson & Johnson|\n| Abbott Laboratories|\n| Abbott Laboratories|\n|   Johnson & Johnson|\n|   Johnson & Johnson|\n| Abbott Laboratories|\n|              AbbVie|\n|              AbbVie|\n|              Pfizer|\n|              Pfizer|\n|Bristol-Myers Squibb|\n|               Amgen|\n|               Amgen|\n|               Amgen|\n|Amneal Pharmaceut...|\n|     Astellas Pharma|\n+--------------------+\nonly showing top 20 rows\n\n+--------------------+\n|             Sponsor|\n+--------------------+\n|The University of...|\n|     Duke University|\n|Universidade Fede...|\n|Istanbul Medeniye...|\n|University of Rom...|\n|Consorzio Futuro ...|\n|   Ankara University|\n|     Ruijin Hospital|\n|Washington Univer...|\n|           Orphazyme|\n|    Novo Nordisk A/S|\n|Daniel Alexandre ...|\n|Bulent Ecevit Uni...|\n|Institut für Phar...|\n|The Third Xiangya...|\n|Tel Aviv Medical ...|\n|Medicines for Mal...|\n|James Cook Univer...|\n|Soonchunhyang Uni...|\n|Member Companies ...|\n+--------------------+\nonly showing top 20 rows\n\n+--------------------+\n|             Sponsor|\n+--------------------+\n|The University of...|\n|     Duke University|\n|Universidade Fede...|\n|Istanbul Medeniye...|\n|University of Rom...|\n|Consorzio Futuro ...|\n|   Ankara University|\n|     Ruijin Hospital|\n|Washington Univer...|\n|           Orphazyme|\n|    Novo Nordisk A/S|\n|Daniel Alexandre ...|\n|Bulent Ecevit Uni...|\n|Institut für Phar...|\n|The Third Xiangya...|\n|Tel Aviv Medical ...|\n|Medicines for Mal...|\n|James Cook Univer...|\n|Soonchunhyang Uni...|\n|Member Companies ...|\n+--------------------+\nonly showing top 20 rows\n\n+--------------------+-----+\n|             Sponsor|count|\n+--------------------+-----+\n|National Cancer I...| 3218|\n|M.D. Anderson Can...| 2414|\n|Assistance Publiq...| 2369|\n|         Mayo Clinic| 2300|\n|Merck Sharp & Doh...| 2243|\n|   Assiut University| 2154|\n|Novartis Pharmace...| 2088|\n|Massachusetts Gen...| 1971|\n|    Cairo University| 1928|\n|   Hoffmann-La Roche| 1828|\n+--------------------+-----+\nonly showing top 10 rows\n\n","removedWidgets":[],"addedWidgets":{},"metadata":{},"type":"ansi","arguments":{}}},"output_type":"display_data","data":{"text/plain":["+--------------------+--------------------+--------------+------------------------+---------------------------------------------------------+------------+------------+--------------------+--------------------+--------------------+--------------------+-------------------+-------------+--------------------+------------------+---------------------+-----+---------------+-----------------------------+------------------+--------------+------------+--------------------+-----+----------+--------------------+--------------------+------------------+-------------------+---------------------------+------------------------+---------------------------+--------------------+--------------------+\n|             Company|      Parent_Company|Penalty_Amount|Subtraction_From_Penalty|Penalty_Amount_Adjusted_For_Eliminating_Multiple_Counting|Penalty_Year|Penalty_Date|       Offense_Group|     Primary_Offense|   Secondary_Offense|         Description|Level_of_Government|  Action_Type|              Agency|    Civil/Criminal|Prosecution_Agreement|Court|        Case_ID|Private_Litigation_Case_Title|Lawsuit_Resolution|Facility_State|        City|             Address|  Zip|NAICS_Code|   NAICS_Translation|HQ_Country_of_Parent|HQ_State_of_Parent|Ownership_Structure|Parent_Company_Stock_Ticker|Major_Industry_of_Parent|Specific_Industry_of_Parent|         Info_Source|               Notes|\n+--------------------+--------------------+--------------+------------------------+---------------------------------------------------------+------------+------------+--------------------+--------------------+--------------------+--------------------+-------------------+-------------+--------------------+------------------+---------------------+-----+---------------+-----------------------------+------------------+--------------+------------+--------------------+-----+----------+--------------------+--------------------+------------------+-------------------+---------------------------+------------------------+---------------------------+--------------------+--------------------+\n| Abbott Laboratories| Abbott Laboratories|    $5,475,000|                      $0|                                               $5,475,000|        2013|    20131227|government-contra...|False Claims Act ...|kickbacks and bri...|Abbott Laboratori...|            federal|agency action|Justice Departmen...|             civil|                 null| null|           null|                         null|              null|          null|        null|                null| null|      null|                null|                 USA|          Illinois|    publicly traded|                        ABT|         pharmaceuticals|            pharmaceuticals|https://www.justi...|                null|\n|Abbott Laboratori...|              AbbVie|$1,500,000,000|                      $0|                                           $1,500,000,000|        2012|    20120507|healthcare-relate...|off-label or unap...|                null|Global Health Car...|            federal|agency action|Food and Drug Adm...|civil and criminal|                 null| null|           null|                         null|              null|          null|        null|                null| null|      null|                null|                 USA|          Illinois|    publicly traded|                       ABBV|         pharmaceuticals|            pharmaceuticals|http://www.justic...|                null|\n|Abbott Laboratori...|              AbbVie|  $126,500,000|                      $0|                                             $126,500,000|        2010|    20101207|government-contra...|False Claims Act ...|                null|Abbott Laboratori...|            federal|agency action|Justice Departmen...|             civil|                 null| null|           null|                         null|              null|          null|        null|                null| null|      null|                null|                 USA|          Illinois|    publicly traded|                       ABBV|         pharmaceuticals|            pharmaceuticals|https://www.justi...|                null|\n|Abbott Laboratori...| Abbott Laboratories|       $49,045|                      $0|                                                  $49,045|        2009|    20090305|employment-relate...|wage and hour vio...|Fair Labor Standa...|                null|            federal|agency action|Labor Department ...|             civil|                 null| null|        1527129|                         null|              null|   Puerto Rico|    San Juan|                null| null|    423450|423450: Medical, ...|                 USA|          Illinois|    publicly traded|                        ABT|         pharmaceuticals|            pharmaceuticals|March 7, 2017 dow...|Date and year are...|\n|      Acclarent Inc.|   Johnson & Johnson|   $18,000,000|                      $0|                                              $18,000,000|        2016|    20160722|government-contra...|False Claims Act ...|                null|California-based ...|            federal|agency action|Justice Departmen...|             civil|                 null| null|           null|                         null|              null|          null|        null|                null| null|      null|                null|                 USA|        New Jersey|    publicly traded|                        JNJ|         pharmaceuticals|            pharmaceuticals|https://www.justi...|                null|\n|Advanced Medical ...| Abbott Laboratories|       $16,800|                      $0|                                                  $16,800|        2004|    20040412|employment-relate...|labor relations v...|                null|back pay award in...|            federal|agency action|National Labor Re...|             civil|                 null| null|21-CA-36104-001|                         null|              null|    California|      Irvine|                null|92606|    333314|333314: Optical I...|                 USA|          Illinois|    publicly traded|                        ABT|         pharmaceuticals|            pharmaceuticals|Extracted from an...|                null|\n|Advanced Neuromod...| Abbott Laboratories|    $2,950,000|                      $0|                                               $2,950,000|        2007|    20070702|healthcare-relate...|HHS civil monetar...|kickbacks and bri...|The HHS Inspector...|            federal|agency action|Health & Human Se...|             civil|                 null| null|           null|                         null|              null|          null|        null|                null| null|      null|                null|                 USA|          Illinois|    publicly traded|                        ABT|         pharmaceuticals|            pharmaceuticals|https://oig.hhs.g...|                null|\n|Advanced Steriliz...|   Johnson & Johnson|      $136,800|                      $0|                                                 $136,800|        2014|    20140520|environment-relat...|environmental vio...|                null|The U.S. Environm...|            federal|agency action|Environmental Pro...|             civil|                 null| null|           null|                         null|              null|    California|      Irvine|                null| null|      null|                null|                 USA|        New Jersey|    publicly traded|                        JNJ|         pharmaceuticals|            pharmaceuticals|https://archive.e...|                null|\n|Advanced Steriliz...|   Johnson & Johnson|    $1,200,000|                      $0|                                               $1,200,000|        2013|    20131204|safety-related of...|drug or medical e...|                null|Settlement of a c...|            federal|agency action|Food and Drug Adm...|             civil|                 null| null|           null|                         null|              null|    California|      Irvine|                null| null|      null|                null|                 USA|        New Jersey|    publicly traded|                        JNJ|         pharmaceuticals|            pharmaceuticals|http://www.fda.go...|                null|\n|Alere San Diego Inc.| Abbott Laboratories|       $10,572|                      $0|                                                  $10,572|        2017|    20170309|employment-relate...|wage and hour vio...|Fair Labor Standa...|                null|            federal|agency action|Labor Department ...|             civil|                 null| null|        1813371|                         null|              null|    California|      Pomona|828 Towne Center Dr.|91767|      null|                null|                 USA|          Illinois|    publicly traded|                        ABT|         pharmaceuticals|            pharmaceuticals|July 23, 2017 dow...|Date and year are...|\n|       Allergan Inc.|              AbbVie|  $600,000,000|                      $0|                                             $600,000,000|        2010|    20100901|healthcare-relate...|off-label or unap...|                null|American pharmace...|            federal|agency action|Food and Drug Adm...|civil and criminal|                 null| null|           null|                         null|              null|          null|        null|                null| null|      null|                null|                 USA|          Illinois|    publicly traded|                       ABBV|         pharmaceuticals|            pharmaceuticals|http://www.justic...|                null|\n|       Allergan Inc.|              AbbVie|   $15,000,000|                      $0|                                              $15,000,000|        2017|    20170117|  financial offenses|investor protecti...|                null|Allergan Inc. adm...|            federal|agency action|Securities and Ex...|             civil|                 null| null|           null|                         null|              null|          null|        null|                null| null|      null|                null|                 USA|          Illinois|    publicly traded|                       ABBV|         pharmaceuticals|            pharmaceuticals|https://www.sec.g...|                null|\n|       Alpharma Inc.|              Pfizer|   $42,500,000|                      $0|                                              $42,500,000|        2010|    20100316|government-contra...|False Claims Act ...|kickbacks and bri...|Alpharma Inc. agr...|            federal|agency action|Justice Departmen...|             civil|                 null| null|           null|                         null|              null|          null|        null|                null| null|      null|                null|                 USA|          New York|    publicly traded|                        PFE|         pharmaceuticals|            pharmaceuticals|https://www.justi...|                null|\n|      Alpharma, Inc.|              Pfizer|    $2,500,000|                      $0|                                               $2,500,000|        2004|    20040812|competition-relat...|price-fixing or a...|consumer protecti...|Generic drug manu...|            federal|agency action|Federal Trade Com...|             civil|                 null| null|           null|                         null|              null|          null|        null|                null| null|      null|                null|                 USA|          New York|    publicly traded|                        PFE|         pharmaceuticals|            pharmaceuticals|https://www.ftc.g...|                null|\n|American Pharmace...|Bristol-Myers Squibb|      $160,203|                      $0|                                                 $160,203|        2004|    20041226|employment-relate...|wage and hour vio...|Fair Labor Standa...|                null|            federal|agency action|Labor Department ...|             civil|                 null| null|        1379241|                         null|              null|      New York|Grand Island|                null|14072|     32541|32541: Pharmaceut...|                 USA|          New York|    publicly traded|                        BMY|         pharmaceuticals|            pharmaceuticals|March 7, 2017 dow...|Date and year are...|\n|          Amgen Inc.|               Amgen|  $762,000,000|                      $0|                                             $762,000,000|        2012|    20121219|healthcare-relate...|off-label or unap...|                null|U.S. District Jud...|            federal|agency action|Food and Drug Adm...|civil and criminal|                 null| null|           null|                         null|              null|          null|        null|                null| null|      null|                null|                 USA|        California|    publicly traded|                       AMGN|         pharmaceuticals|            pharmaceuticals|http://www.justic...|                null|\n|          Amgen Inc.|               Amgen|   $24,900,000|                      $0|                                              $24,900,000|        2013|    20130416|government-contra...|False Claims Act ...|kickbacks and bri...|\"Amgen Inc. agree...|            federal|agency action|Justice Departmen...|             civil|                 null| null|           null|                         null|              null|          null|        null|                null| null|      null|                null|                 USA|        California|    publicly traded|                       AMGN|         pharmaceuticals|            pharmaceuticals|https://www.justi...|                null|\n|         Amgen, Inc.|               Amgen|       $40,000|                      $0|                                                  $40,000|        2011|    20110302|employment-relate...|labor relations v...|                null|back pay award in...|            federal|agency action|National Labor Re...|             civil|                 null| null|14-CA-30273-001|                         null|              null|      Missouri|   St. Louis|                null|63130|    541720|541720: Research ...|                 USA|        California|    publicly traded|                       AMGN|         pharmaceuticals|            pharmaceuticals|Extracted from an...|                null|\n|Amneal Pharmaceut...|Amneal Pharmaceut...|       $99,000|                      $0|                                                  $99,000|        2015|    20150930|employment-relate...|employment discri...|                null|                null|            federal|agency action|Office of Federal...|             civil|                 null| null|           null|                         null|              null|          null|        null|                null| null|      null|                null|                 USA|        New Jersey|    publicly traded|                       AMRX|         pharmaceuticals|            pharmaceuticals|https://www.dol.g...|                null|\n|Astellas Pharma U...|     Astellas Pharma|    $7,300,000|                      $0|                                               $7,300,000|        2014|    20140416|government-contra...|False Claims Act ...|off-label or unap...|Astellas Pharma U...|            federal|agency action|Justice Departmen...|             civil|                 null| null|           null|                         null|              null|          null|        null|                null| null|      null|                null|               Japan|              null|    publicly traded|                       null|         pharmaceuticals|            pharmaceuticals|https://www.justi...|                null|\n+--------------------+--------------------+--------------+------------------------+---------------------------------------------------------+------------+------------+--------------------+--------------------+--------------------+--------------------+-------------------+-------------+--------------------+------------------+---------------------+-----+---------------+-----------------------------+------------------+--------------+------------+--------------------+-----+----------+--------------------+--------------------+------------------+-------------------+---------------------------+------------------------+---------------------------+--------------------+--------------------+\nonly showing top 20 rows\n\n+--------------------+\n|      Parent_Company|\n+--------------------+\n| Abbott Laboratories|\n|              AbbVie|\n|              AbbVie|\n| Abbott Laboratories|\n|   Johnson & Johnson|\n| Abbott Laboratories|\n| Abbott Laboratories|\n|   Johnson & Johnson|\n|   Johnson & Johnson|\n| Abbott Laboratories|\n|              AbbVie|\n|              AbbVie|\n|              Pfizer|\n|              Pfizer|\n|Bristol-Myers Squibb|\n|               Amgen|\n|               Amgen|\n|               Amgen|\n|Amneal Pharmaceut...|\n|     Astellas Pharma|\n+--------------------+\nonly showing top 20 rows\n\n+--------------------+\n|             Sponsor|\n+--------------------+\n|The University of...|\n|     Duke University|\n|Universidade Fede...|\n|Istanbul Medeniye...|\n|University of Rom...|\n|Consorzio Futuro ...|\n|   Ankara University|\n|     Ruijin Hospital|\n|Washington Univer...|\n|           Orphazyme|\n|    Novo Nordisk A/S|\n|Daniel Alexandre ...|\n|Bulent Ecevit Uni...|\n|Institut für Phar...|\n|The Third Xiangya...|\n|Tel Aviv Medical ...|\n|Medicines for Mal...|\n|James Cook Univer...|\n|Soonchunhyang Uni...|\n|Member Companies ...|\n+--------------------+\nonly showing top 20 rows\n\n+--------------------+\n|             Sponsor|\n+--------------------+\n|The University of...|\n|     Duke University|\n|Universidade Fede...|\n|Istanbul Medeniye...|\n|University of Rom...|\n|Consorzio Futuro ...|\n|   Ankara University|\n|     Ruijin Hospital|\n|Washington Univer...|\n|           Orphazyme|\n|    Novo Nordisk A/S|\n|Daniel Alexandre ...|\n|Bulent Ecevit Uni...|\n|Institut für Phar...|\n|The Third Xiangya...|\n|Tel Aviv Medical ...|\n|Medicines for Mal...|\n|James Cook Univer...|\n|Soonchunhyang Uni...|\n|Member Companies ...|\n+--------------------+\nonly showing top 20 rows\n\n+--------------------+-----+\n|             Sponsor|count|\n+--------------------+-----+\n|National Cancer I...| 3218|\n|M.D. Anderson Can...| 2414|\n|Assistance Publiq...| 2369|\n|         Mayo Clinic| 2300|\n|Merck Sharp & Doh...| 2243|\n|   Assiut University| 2154|\n|Novartis Pharmace...| 2088|\n|Massachusetts Gen...| 1971|\n|    Cairo University| 1928|\n|   Hoffmann-La Roche| 1828|\n+--------------------+-----+\nonly showing top 10 rows\n\n"]}}],"execution_count":0},{"cell_type":"code","source":["#Problem6\nfrom pyspark.sql.functions import col\nfrom pyspark.sql.functions import split\ncltrial_date_df=clinicaltrial_2021.where(clinicaltrial_2021.Status=='Completed')\n#cltrial_date_df.show()\ncltrial_date_df1=cltrial_date_df.withColumn(\"Completion_month\",split(col(\"Completion\"),\" \").getItem(0)).withColumn(\"Completion_year\",split(col(\"Completion\"),\" \").getItem(1))\n#cltrial_date_df1.show()\ncltrial_date_df2=cltrial_date_df1.where(cltrial_date_df1.Completion_year==\"2021\")\n#cltrial_date_df2.show()\ncltrial_date_df3=cltrial_date_df2.groupBy('Completion_month').count().orderBy('count')\ncltrial_date_df3.show()\ncltrial_mon=spark.createDataFrame([(\"Jan\"),(\"Feb\"),(\"Mar\"),(\"Apr\"),(\"May\"),(\"Jun\"),(\"Jul\"),(\"Aug\"),(\"Sep\"),(\"Oct\")],\"string\").toDF(\"Month\")\ncltrial_mon.show()\n#Order by Month in ascending order of Completion month frequency\ncltrial_month=cltrial_date_df3.join(cltrial_mon,cltrial_date_df3.Completion_month==cltrial_mon.Month,'right')\ncltrial_month=cltrial_month.drop(cltrial_month.Completion_month)\ncltrial_month.show()"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"9a2c6235-dd4f-4a09-94e0-7d8c1c822e2e"}},"outputs":[{"output_type":"display_data","metadata":{"application/vnd.databricks.v1+output":{"datasetInfos":[],"data":"+----------------+-----+\n|Completion_month|count|\n+----------------+-----+\n|             Oct|  187|\n|             Sep|  528|\n|             Aug|  700|\n|             Jul|  819|\n|             Feb|  934|\n|             Apr|  967|\n|             May|  984|\n|             Jun| 1094|\n|             Jan| 1131|\n|             Mar| 1227|\n+----------------+-----+\n\n+-----+\n|Month|\n+-----+\n|  Jan|\n|  Feb|\n|  Mar|\n|  Apr|\n|  May|\n|  Jun|\n|  Jul|\n|  Aug|\n|  Sep|\n|  Oct|\n+-----+\n\n+-----+-----+\n|count|Month|\n+-----+-----+\n| 1131|  Jan|\n|  934|  Feb|\n| 1227|  Mar|\n|  967|  Apr|\n|  984|  May|\n| 1094|  Jun|\n|  819|  Jul|\n|  700|  Aug|\n|  528|  Sep|\n|  187|  Oct|\n+-----+-----+\n\n","removedWidgets":[],"addedWidgets":{},"metadata":{},"type":"ansi","arguments":{}}},"output_type":"display_data","data":{"text/plain":["+----------------+-----+\n|Completion_month|count|\n+----------------+-----+\n|             Oct|  187|\n|             Sep|  528|\n|             Aug|  700|\n|             Jul|  819|\n|             Feb|  934|\n|             Apr|  967|\n|             May|  984|\n|             Jun| 1094|\n|             Jan| 1131|\n|             Mar| 1227|\n+----------------+-----+\n\n+-----+\n|Month|\n+-----+\n|  Jan|\n|  Feb|\n|  Mar|\n|  Apr|\n|  May|\n|  Jun|\n|  Jul|\n|  Aug|\n|  Sep|\n|  Oct|\n+-----+\n\n+-----+-----+\n|count|Month|\n+-----+-----+\n| 1131|  Jan|\n|  934|  Feb|\n| 1227|  Mar|\n|  967|  Apr|\n|  984|  May|\n| 1094|  Jun|\n|  819|  Jul|\n|  700|  Aug|\n|  528|  Sep|\n|  187|  Oct|\n+-----+-----+\n\n"]}}],"execution_count":0},{"cell_type":"code","source":["cltrial_date_Jan=cltrial_date_df2.where(cltrial_date_df2.Completion_month=='Jan').show()\ncltrial_date_Feb=cltrial_date_df2.where(cltrial_date_df2.Completion_month=='Feb').show()\ncltrial_date_Mar=cltrial_date_df2.where(cltrial_date_df2.Completion_month=='Mar').show()\ncltrial_date_April=cltrial_date_df2.where(cltrial_date_df2.Completion_month=='April').show()\ncltrial_date_May=cltrial_date_df2.where(cltrial_date_df2.Completion_month=='May').show()\ncltrial_date_Jun=cltrial_date_df2.where(cltrial_date_df2.Completion_month=='Jun').show()\ncltrial_date_July=cltrial_date_df2.where(cltrial_date_df2.Completion_month=='Jul').show()\ncltrial_date_Aug=cltrial_date_df2.where(cltrial_date_df2.Completion_month=='Aug').show()\ncltrial_date_Sep=cltrial_date_df2.where(cltrial_date_df2.Completion_month=='Sep').show()\ncltrial_date_Oct=cltrial_date_df2.where(cltrial_date_df2.Completion_month=='Oct').show()\ncltrial_date_Nov=cltrial_date_df2.where(cltrial_date_df2.Completion_month=='Nov').show()\ncltrial_date_Dec=cltrial_date_df2.where(cltrial_date_df2.Completion_month=='Dec').show()"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"127da45d-4f6e-43fb-9619-843b4a683ced"}},"outputs":[{"output_type":"display_data","metadata":{"application/vnd.databricks.v1+output":{"datasetInfos":[],"data":"+-----------+--------------------+---------+--------+----------+--------------------+----------+--------------------+--------------------+----------------+---------------+\n|         Id|             Sponsor|   Status|   Start|Completion|                Type|Submission|          Conditions|       Interventions|Completion_month|Completion_year|\n+-----------+--------------------+---------+--------+----------+--------------------+----------+--------------------+--------------------+----------------+---------------+\n|NCT02753530|           Orphazyme|Completed|Aug 2017|  Jan 2021|      Interventional|  Apr 2016|            Myositis|                null|             Jan|           2021|\n|NCT02758782|Charite Universit...|Completed|Sep 2016|  Jan 2021|      Interventional|  Apr 2016|         Spondylitis| Celecoxib,Golimumab|             Jan|           2021|\n|NCT03095209|Fox Chase Cancer ...|Completed|Feb 2017|  Jan 2021|       Observational|  Mar 2017|Lung Neoplasms,Es...|Paclitaxel,Carbop...|             Jan|           2021|\n|NCT03096834|Novartis Pharmace...|Completed|Mar 2017|  Jan 2021|      Interventional|  Mar 2017|  Migraine Disorders|            Erenumab|             Jan|           2021|\n|NCT03090854|Assistance Publiq...|Completed|Nov 2017|  Jan 2021|       Observational|  Feb 2017|   Alzheimer Disease|                null|             Jan|           2021|\n|NCT03922828|Singapore General...|Completed|May 2018|  Jan 2021|Observational [Pa...|  Apr 2019|Lung Neoplasms,Ad...|                null|             Jan|           2021|\n|NCT03922841|Singapore General...|Completed|Mar 2018|  Jan 2021|Observational [Pa...|  Apr 2019|    Pleural Diseases|                null|             Jan|           2021|\n|NCT03923595|   Alessandra Mangia|Completed|Jul 2019|  Jan 2021|       Observational|  Apr 2019|         Hepatitis C|                null|             Jan|           2021|\n|NCT03927846|Wake Forest Unive...|Completed|Jul 2019|  Jan 2021|      Interventional|  Apr 2019|Musculoskeletal Pain|                null|             Jan|           2021|\n|NCT03926845|Institute of Derm...|Completed|Apr 2019|  Jan 2021|      Interventional|  Apr 2019|Hyperpigmentation...|                null|             Jan|           2021|\n|NCT03925779| Menoufia University|Completed|Jun 2019|  Jan 2021|      Interventional|  Apr 2019|                null|Dexmedetomidine,R...|             Jan|           2021|\n|NCT02540681|Major Extremity T...|Completed|Jan 2015|  Jan 2021|       Observational|  Jun 2015|          Amputation|                null|             Jan|           2021|\n|NCT02546531|Washington Univer...|Completed|Feb 2016|  Jan 2021|      Interventional|  Aug 2015|                null|Gemcitabine,Pembr...|             Jan|           2021|\n|NCT02549131|Mednax Center for...|Completed|Sep 2015|  Jan 2021|      Interventional|  Aug 2015|                null|                null|             Jan|           2021|\n|NCT02547493|University Hospit...|Completed|Mar 2016|  Jan 2021|      Interventional|  Sep 2015|           Arthritis|Abatacept,Vaccine...|             Jan|           2021|\n|NCT02547922|         AstraZeneca|Completed|Nov 2015|  Jan 2021|      Interventional|  Aug 2015|Nephritis,Lupus N...|                null|             Jan|           2021|\n|NCT04292301|      SpinTech, Inc.|Completed|Jun 2020|  Jan 2021|      Interventional|  Feb 2020|                null|                null|             Jan|           2021|\n|NCT04296721|Hospital Universi...|Completed|Jan 2019|  Jan 2021|      Interventional|  Mar 2020|Apnea,Sleep Apnea...|                null|             Jan|           2021|\n|NCT04291339|   Yonsei University|Completed|Nov 2020|  Jan 2021|      Interventional|  Feb 2020|                null|                null|             Jan|           2021|\n|NCT04295876|University of Cal...|Completed|Dec 2019|  Jan 2021|      Interventional|  Mar 2020|Acquired Immunode...|                null|             Jan|           2021|\n+-----------+--------------------+---------+--------+----------+--------------------+----------+--------------------+--------------------+----------------+---------------+\nonly showing top 20 rows\n\n+-----------+--------------------+---------+--------+----------+--------------+----------+--------------------+--------------------+----------------+---------------+\n|         Id|             Sponsor|   Status|   Start|Completion|          Type|Submission|          Conditions|       Interventions|Completion_month|Completion_year|\n+-----------+--------------------+---------+--------+----------+--------------+----------+--------------------+--------------------+----------------+---------------+\n|NCT02759575|       Vinita Takiar|Completed|Apr 2016|  Feb 2021|Interventional|  Apr 2016|Carcinoma,Squamou...|       Pembrolizumab|             Feb|           2021|\n|NCT02758626|  NYU Langone Health|Completed|Nov 2016|  Feb 2021|Interventional|  Apr 2016| Epilepsy,Epilepsies|                null|             Feb|           2021|\n|NCT02750670|University Health...|Completed|Mar 2017|  Feb 2021|Interventional|  Apr 2016|            Lymphoma|Gemcitabine,Dexam...|             Feb|           2021|\n|NCT03093480|Bioverativ, a San...|Completed|Dec 2017|  Feb 2021|Interventional|  Mar 2017|        Hemophilia A|         Factor VIII|             Feb|           2021|\n|NCT03092505|National Institut...|Completed|Jun 2018|  Feb 2021| Observational|  Mar 2017|                null|                null|             Feb|           2021|\n|NCT03926442|Clinical Nutritio...|Completed|Apr 2019|  Feb 2021|Interventional|  Apr 2019|                null|                null|             Feb|           2021|\n|NCT03929263|Oklahoma State Un...|Completed|Sep 2019|  Feb 2021|Interventional|  Apr 2019|                null|                null|             Feb|           2021|\n|NCT01455831|Ottawa Hospital R...|Completed|Sep 2011|  Feb 2021|Interventional|  Oct 2011|Colorectal Neopla...|Tinzaparin,Hepari...|             Feb|           2021|\n|NCT01827501|Technische Univer...|Completed|Apr 2013|  Feb 2021|Interventional|  Apr 2013|            Delirium|                null|             Feb|           2021|\n|NCT02545049|               Bayer|Completed|Sep 2015|  Feb 2021|Interventional|  Sep 2015|Kidney Diseases,D...|                null|             Feb|           2021|\n|NCT04297644|     Intelomed, Inc.|Completed|Nov 2020|  Feb 2021| Observational|  Mar 2020|                null|                null|             Feb|           2021|\n|NCT04296201|        Lumenis Ltd.|Completed|Sep 2020|  Feb 2021|Interventional|  Mar 2020|         Contracture|                null|             Feb|           2021|\n|NCT04297072|               Bayer|Completed|May 2020|  Feb 2021| Observational|  Mar 2020| Atrial Fibrillation|         Rivaroxaban|             Feb|           2021|\n|NCT04297007|  Medipol University|Completed|Mar 2020|  Feb 2021|Interventional|  Feb 2020|Breast Neoplasms,...|                null|             Feb|           2021|\n|NCT00579631|Memorial Sloan Ke...|Completed|Jun 2004|  Feb 2021| Observational|  Dec 2007|                null|                null|             Feb|           2021|\n|NCT03824860|Dana-Farber Cance...|Completed|Aug 2019|  Feb 2021|Interventional|  Jan 2019|Peripheral Nervou...|                null|             Feb|           2021|\n|NCT03828669| Stanford University|Completed|Jan 2019|  Feb 2021| Observational|  Jan 2019|                Pain|                null|             Feb|           2021|\n|NCT03820284|   Assiut University|Completed|Feb 2019|  Feb 2021| Observational|  Jan 2019|Helicobacter Infe...|                null|             Feb|           2021|\n|NCT03825380|   Laboratoires Thea|Completed|Nov 2018|  Feb 2021|Interventional|  Jan 2019| Ocular Hypertension|         Bimatoprost|             Feb|           2021|\n|NCT01901289|Cook Research Inc...|Completed|Aug 2013|  Feb 2021|Interventional|  Jul 2013|Peripheral Arteri...|                null|             Feb|           2021|\n+-----------+--------------------+---------+--------+----------+--------------+----------+--------------------+--------------------+----------------+---------------+\nonly showing top 20 rows\n\n+-----------+--------------------+---------+--------+----------+--------------------+----------+--------------------+--------------------+----------------+---------------+\n|         Id|             Sponsor|   Status|   Start|Completion|                Type|Submission|          Conditions|       Interventions|Completion_month|Completion_year|\n+-----------+--------------------+---------+--------+----------+--------------------+----------+--------------------+--------------------+----------------+---------------+\n|NCT02754778|Martin-Luther-Uni...|Completed|Apr 2016|  Mar 2021|      Interventional|  Apr 2016|Pre-Eclampsia,HEL...|                null|             Mar|           2021|\n|NCT02753309|The University of...|Completed|Jun 2016|  Mar 2021|      Interventional|  Apr 2016|Urinary Bladder N...|           Sirolimus|             Mar|           2021|\n|NCT03094247|Washington Univer...|Completed|Oct 2017|  Mar 2021|      Interventional|  Mar 2017|Malnutrition,Seve...|         Amoxicillin|             Mar|           2021|\n|NCT03924752|Georgia Institute...|Completed|Aug 2019|  Mar 2021|      Interventional|  Apr 2019|        Leg Injuries|                null|             Mar|           2021|\n|NCT03920046|TC Erciyes Univer...|Completed|Jan 2019|  Mar 2021|Observational [Pa...|  Apr 2019|Intestinal Diseas...|                null|             Mar|           2021|\n|NCT03928925|Vanderbilt Univer...|Completed|Apr 2019|  Mar 2021|      Interventional|  Apr 2019|Respiratory Insuf...|                null|             Mar|           2021|\n|NCT03924843|University Medica...|Completed|Nov 2017|  Mar 2021|       Observational|  Mar 2019|                null|                null|             Mar|           2021|\n|NCT03928821|National Institut...|Completed|Jul 2019|  Mar 2021|      Interventional|  Apr 2019|      HIV Infections|                null|             Mar|           2021|\n|NCT03927313|University of Cap...|Completed|Jun 2019|  Mar 2021|      Interventional|  Mar 2019|Tuberculosis,Meni...|Aspirin,Rifampin,...|             Mar|           2021|\n|NCT03922867|         Mayo Clinic|Completed|Dec 2019|  Mar 2021|      Interventional|  Apr 2019|Fibromyalgia,Myof...|                null|             Mar|           2021|\n|NCT03924427|Bristol-Myers Squibb|Completed|Apr 2019|  Mar 2021|      Interventional|  Apr 2019|           Psoriasis|          BMS-986165|             Mar|           2021|\n|NCT02287740|Oregon Research I...|Completed|Nov 2014|  Mar 2021|      Interventional|  Oct 2014|                null|                null|             Mar|           2021|\n|NCT01824290|Eli Lilly and Com...|Completed|Feb 2014|  Mar 2021|      Interventional|  Apr 2013|Pulmonary Arteria...|           Tadalafil|             Mar|           2021|\n|NCT02546674|Novartis Pharmace...|Completed|Feb 2016|  Mar 2021|      Interventional|  Sep 2015|            Leukemia|                null|             Mar|           2021|\n|NCT04298164|University Colleg...|Completed|Nov 2019|  Mar 2021|      Interventional|  Feb 2020|Autistic Disorder...|                null|             Mar|           2021|\n|NCT04291547|  University of York|Completed|Jun 2020|  Mar 2021|      Interventional|  Feb 2020|Depression,Depres...|                null|             Mar|           2021|\n|NCT04294147|Eli Lilly and Com...|Completed|Oct 2020|  Mar 2021|      Interventional|  Mar 2020|  Migraine Disorders|            Erenumab|             Mar|           2021|\n|NCT04299672|Universidad Anton...|Completed|Mar 2020|  Mar 2021|      Interventional|  Nov 2019|                null|                null|             Mar|           2021|\n|NCT04292626|Tomsk National Re...|Completed|Jan 2020|  Mar 2021|      Interventional|  Feb 2020|Lymphoma,Hodgkin ...|                null|             Mar|           2021|\n|NCT00578994|Biomet Orthopedic...|Completed|Mar 2006|  Mar 2021|       Observational|  Dec 2007|            Necrosis|                null|             Mar|           2021|\n+-----------+--------------------+---------+--------+----------+--------------------+----------+--------------------+--------------------+----------------+---------------+\nonly showing top 20 rows\n\n+---+-------+------+-----+----------+----+----------+----------+-------------+----------------+---------------+\n| Id|Sponsor|Status|Start|Completion|Type|Submission|Conditions|Interventions|Completion_month|Completion_year|\n+---+-------+------+-----+----------+----+----------+----------+-------------+----------------+---------------+\n+---+-------+------+-----+----------+----+----------+----------+-------------+----------------+---------------+\n\n+-----------+--------------------+---------+--------+----------+--------------+----------+--------------------+--------------------+----------------+---------------+\n|         Id|             Sponsor|   Status|   Start|Completion|          Type|Submission|          Conditions|       Interventions|Completion_month|Completion_year|\n+-----------+--------------------+---------+--------+----------+--------------+----------+--------------------+--------------------+----------------+---------------+\n|NCT02751151|Inova Health Care...|Completed|Feb 2016|  May 2021|Interventional|  Mar 2016|      Skin Neoplasms| Aminolevulinic Acid|             May|           2021|\n|NCT02755402|Centre hospitalie...|Completed|Jan 2017|  May 2021|Interventional|  Apr 2016|         Hepatitis C|                null|             May|           2021|\n|NCT02750215|Massachusetts Gen...|Completed|May 2016|  May 2021|Interventional|  Apr 2016|      Lung Neoplasms|                null|             May|           2021|\n|NCT02757443|Meshalkin Researc...|Completed|Jun 2016|  May 2021|Interventional|  Apr 2016|                null|Phosphocreatine,A...|             May|           2021|\n|NCT02757313|     Yale University|Completed|Oct 2016|  May 2021|Interventional|  Apr 2016|     Marijuana Abuse|          Dronabinol|             May|           2021|\n|NCT02753127|Sumitomo Dainippo...|Completed|Jun 2016|  May 2021|Interventional|  Apr 2016|Colorectal Neoplasms|Leucovorin,Bevaci...|             May|           2021|\n|NCT03093038|       JointResearch|Completed|May 2014|  May 2021|Interventional|  Dec 2014|      Osteoarthritis|                null|             May|           2021|\n|NCT03926793|GB002, Inc., a wh...|Completed|Feb 2020|  May 2021|Interventional|  Apr 2019|Pulmonary Arteria...|                null|             May|           2021|\n|NCT03925337|Beth Israel Deaco...|Completed|May 2019|  May 2021|Interventional|  Apr 2019|Adenomatous Polyp...|                null|             May|           2021|\n|NCT03921424|Merck Sharp & Doh...|Completed|Nov 2019|  May 2021|Interventional|  Apr 2019|Acquired Immunode...|Heptavalent Pneum...|             May|           2021|\n|NCT03925571|Nantes University...|Completed|May 2019|  May 2021|Interventional|  Apr 2019|Sensation Disorde...|                null|             May|           2021|\n|NCT03920397|Universidade Fede...|Completed|Mar 2015|  May 2021|Interventional|  Apr 2019|   Diabetes Mellitus|     Cholecalciferol|             May|           2021|\n|NCT02283775|              Sanofi|Completed|May 2015|  May 2021|Interventional|  Nov 2014|Multiple Myeloma,...|Dexamethasone,Pom...|             May|           2021|\n|NCT01455818|Ottawa Hospital R...|Completed|Mar 2011|  May 2021| Observational|  Oct 2011|Pulmonary Embolis...|                null|             May|           2021|\n|NCT01826877|Jonsson Comprehen...|Completed|Jan 2013|  May 2021|Interventional|  Apr 2013|           Carcinoma|                null|             May|           2021|\n|NCT02541916|University of Tor...|Completed|Apr 2015|  May 2021|Interventional|  Sep 2015|                null|                null|             May|           2021|\n|NCT02543944|University of Ark...|Completed|Feb 2016|  May 2021|Interventional|  Aug 2015|Opioid-Related Di...|Clonidine,Naltrex...|             May|           2021|\n|NCT02544711|Nantes University...|Completed|Dec 2015|  May 2021|Interventional|  Aug 2015|      Bone Neoplasms|                null|             May|           2021|\n|NCT00924937|Hospital Universi...|Completed|Nov 2009|  May 2021|Interventional|  Jun 2009|Myocardial Infarc...|                null|             May|           2021|\n|NCT04294680|     Campbell Clinic|Completed|Aug 2019|  May 2021|Interventional|  Feb 2020|                null|                null|             May|           2021|\n+-----------+--------------------+---------+--------+----------+--------------+----------+--------------------+--------------------+----------------+---------------+\nonly showing top 20 rows\n\n+-----------+--------------------+---------+--------+----------+--------------+----------+--------------------+--------------------+----------------+---------------+\n|         Id|             Sponsor|   Status|   Start|Completion|          Type|Submission|          Conditions|       Interventions|Completion_month|Completion_year|\n+-----------+--------------------+---------+--------+----------+--------------+----------+--------------------+--------------------+----------------+---------------+\n|NCT02758704|St. Justine's Hos...|Completed|Oct 2015|  Jun 2021|Interventional|  Apr 2016|                null|                null|             Jun|           2021|\n|NCT03092713|Oslo University H...|Completed|Jan 2017|  Jun 2021|Interventional|  Mar 2017|      Brain Injuries|                null|             Jun|           2021|\n|NCT03928028|Children's Hospit...|Completed|Apr 2019|  Jun 2021|Interventional|  Apr 2019|Anorexia,Anorexia...|                null|             Jun|           2021|\n|NCT03924089|Fundación Pública...|Completed|Apr 2019|  Jun 2021|Interventional|  Apr 2019|Kidney Failure,Ma...|                null|             Jun|           2021|\n|NCT03924011|  Hasselt University|Completed|Jul 2020|  Jun 2021|Interventional|  Mar 2019|Breast Neoplasms,...|                null|             Jun|           2021|\n|NCT01822509|National Cancer I...|Completed|May 2013|  Jun 2021|Interventional|  Apr 2013|Lymphoma,Leukemia...|Nivolumab,Ipilimumab|             Jun|           2021|\n|NCT01820611|       Zimmer Biomet|Completed|Feb 2013|  Jun 2021| Observational|  Mar 2013|            Necrosis|                null|             Jun|           2021|\n|NCT02540148|The Eye Machine C...|Completed|Nov 2019|  Jun 2021|Interventional|  Sep 2015|Macular Degeneration|                null|             Jun|           2021|\n|NCT02544373|University of Mic...|Completed|Nov 2015|  Jun 2021|Interventional|  May 2015|Multiple Sclerosi...|                null|             Jun|           2021|\n|NCT02542007|          OrbusNeich|Completed|May 2015|  Jun 2021|Interventional|  Sep 2015|Arteriosclerosis,...|           Sirolimus|             Jun|           2021|\n|NCT02542839|University of Flo...|Completed|Nov 2015|  Jun 2021|Interventional|  Jun 2015|Dystonia,Dystonic...|    Botulinum Toxins|             Jun|           2021|\n|NCT02544750|     GW Research Ltd|Completed|Aug 2016|  Jun 2021|Interventional|  Sep 2015|Tuberous Sclerosi...|         Cannabidiol|             Jun|           2021|\n|NCT02544880|Donald T. Weed, M...|Completed|Apr 2016|  Jun 2021|Interventional|  Sep 2015|Carcinoma,Squamou...|  Tadalafil,Vaccines|             Jun|           2021|\n|NCT04298749|      Genexine, Inc.|Completed|Aug 2020|  Jun 2021|Interventional|  Feb 2020| Autoimmune Diseases|                null|             Jun|           2021|\n|NCT04292938| IRCCS Eugenio Medea|Completed|Mar 2019|  Jun 2021|Interventional|  Feb 2020|Glycogen Storage ...|                null|             Jun|           2021|\n|NCT04295200|Louisiana State U...|Completed|Dec 2019|  Jun 2021|Interventional|  Feb 2020|                null|                null|             Jun|           2021|\n|NCT04290910|University of Man...|Completed|Jan 2019|  Jun 2021|Interventional|  Feb 2020|         Weight Loss|                null|             Jun|           2021|\n|NCT04298931|University of Aarhus|Completed|May 2020|  Jun 2021| Observational|  Mar 2020|         Hypovolemia|                null|             Jun|           2021|\n|NCT01912820|Jonsson Comprehen...|Completed|Jan 2014|  Jun 2021|Interventional|  Jul 2013| Prostatic Neoplasms|           Quercetin|             Jun|           2021|\n|NCT01911585|University of Pen...|Completed|Sep 2013|  Jun 2021|Interventional|  Jul 2013|    Stress Disorders|                null|             Jun|           2021|\n+-----------+--------------------+---------+--------+----------+--------------+----------+--------------------+--------------------+----------------+---------------+\nonly showing top 20 rows\n\n+-----------+--------------------+---------+--------+----------+--------------+----------+--------------------+--------------------+----------------+---------------+\n|         Id|             Sponsor|   Status|   Start|Completion|          Type|Submission|          Conditions|       Interventions|Completion_month|Completion_year|\n+-----------+--------------------+---------+--------+----------+--------------+----------+--------------------+--------------------+----------------+---------------+\n|NCT03092063|University of Cal...|Completed|Mar 2017|  Jul 2021|Interventional|  Mar 2017|   Diabetes Mellitus|                null|             Jul|           2021|\n|NCT03093402|National Institut...|Completed|Dec 2017|  Jul 2021|Interventional|  Feb 2017| Lupus Erythematosus|           Lenabasum|             Jul|           2021|\n|NCT03928379|Eli Lilly and Com...|Completed|Oct 2019|  Jul 2021|Interventional|  Apr 2019|   Diabetes Mellitus|                null|             Jul|           2021|\n|NCT03922386|       MicroPort CRM|Completed|Sep 2019|  Jul 2021|Interventional|  Apr 2019|         Bradycardia|                null|             Jul|           2021|\n|NCT01454102|Bristol-Myers Squibb|Completed|Dec 2011|  Jul 2021|Interventional|  Sep 2011|Lung Neoplasms,Ca...|Gemcitabine,Pacli...|             Jul|           2021|\n|NCT02546921|  Cancer Research UK|Completed|Sep 2015|  Jul 2021|Interventional|  Aug 2015|                null|                null|             Jul|           2021|\n|NCT04293497|Gangnam Severance...|Completed|Feb 2020|  Jul 2021|Interventional|  Feb 2020|Pancreatic Neoplasms|                null|             Jul|           2021|\n|NCT04295642|Cerevel Therapeut...|Completed|Jan 2020|  Jul 2021|Interventional|  Jan 2020|   Parkinson Disease|                null|             Jul|           2021|\n|NCT04296032|Taipei Medical Un...|Completed|May 2020|  Jul 2021|Interventional|  Mar 2020|              Stroke|                null|             Jul|           2021|\n|NCT04299165|Kaia Health Software|Completed|Aug 2019|  Jul 2021|Interventional|  Feb 2020|Lung Diseases,Pul...|                null|             Jul|           2021|\n|NCT04291365|Albany Medical Co...|Completed|Mar 2020|  Jul 2021|Interventional|  Feb 2020|                null|                null|             Jul|           2021|\n|NCT04297774|Taipei Medical Un...|Completed|May 2020|  Jul 2021|Interventional|  Mar 2020|              Stroke|                null|             Jul|           2021|\n|NCT00575809|The University of...|Completed|May 2005|  Jul 2021| Observational|  Dec 2007|Mucositis,Stomatitis|                null|             Jul|           2021|\n|NCT00570804|M.D. Anderson Can...|Completed|Dec 2007|  Jul 2021|Interventional|  Dec 2007|    Alcohol Drinking|                null|             Jul|           2021|\n|NCT03821090|   Assiut University|Completed|Jul 2019|  Jul 2021| Observational|  Jan 2019|Arthritis,Atheros...|                null|             Jul|           2021|\n|NCT03822728|Samsung Medical C...|Completed|Aug 2017|  Jul 2021|Interventional|  Jan 2019|Parotid Neoplasms...|                null|             Jul|           2021|\n|NCT04729257|Philips Electroni...|Completed|Mar 2021|  Jul 2021|Interventional|  Jan 2021|                null|                null|             Jul|           2021|\n|NCT04725955|Harokopio University|Completed|Jan 2021|  Jul 2021|Interventional|  Jan 2021|                null|                null|             Jul|           2021|\n|NCT03505099|Novartis Gene The...|Completed|Apr 2018|  Jul 2021|Interventional|  Apr 2018|Muscular Atrophy,...|                null|             Jul|           2021|\n|NCT03501862|The Hong Kong Pol...|Completed|Jan 2017|  Jul 2021|Interventional|  Mar 2018|Psychotic Disorde...|                null|             Jul|           2021|\n+-----------+--------------------+---------+--------+----------+--------------+----------+--------------------+--------------------+----------------+---------------+\nonly showing top 20 rows\n\n+-----------+--------------------+---------+--------+----------+--------------------+----------+--------------------+--------------------+----------------+---------------+\n|         Id|             Sponsor|   Status|   Start|Completion|                Type|Submission|          Conditions|       Interventions|Completion_month|Completion_year|\n+-----------+--------------------+---------+--------+----------+--------------------+----------+--------------------+--------------------+----------------+---------------+\n|NCT02758574|University of Pit...|Completed|May 2016|  Aug 2021|      Interventional|  Mar 2016|Pulmonary Embolis...|                null|             Aug|           2021|\n|NCT03091764|University of Sydney|Completed|Jul 2016|  Aug 2021|Observational [Pa...|  Mar 2017|Urinary Bladder N...|                null|             Aug|           2021|\n|NCT03093779|University of Mic...|Completed|Dec 2016|  Aug 2021|       Observational|  Mar 2017|Hearing Loss,Deaf...|                null|             Aug|           2021|\n|NCT03929562|University of Mic...|Completed|Aug 2019|  Aug 2021|      Interventional|  Apr 2019|    Alcohol Drinking|                null|             Aug|           2021|\n|NCT03926169|              AbbVie|Completed|Jun 2019|  Aug 2021|      Interventional|  Apr 2019|Hidradenitis Supp...|          Antibodies|             Aug|           2021|\n|NCT03925805|    University Ghent|Completed|Nov 2019|  Aug 2021|       Observational|  Apr 2019|Musculoskeletal D...|                null|             Aug|           2021|\n|NCT03928184|Biosplice Therape...|Completed|May 2019|  Aug 2021|      Interventional|  Apr 2019|      Osteoarthritis|        Lorecivivint|             Aug|           2021|\n|NCT03920527|Postgraduate Inst...|Completed|Jul 2019|  Aug 2021|      Interventional|  Apr 2019|Aspergillosis,Pul...|        Itraconazole|             Aug|           2021|\n|NCT03929809|  University of Iowa|Completed|Jun 2019|  Aug 2021|       Observational|  Apr 2019|Hearing Loss,Deaf...|                null|             Aug|           2021|\n|NCT03923192|    Cairo University|Completed|May 2020|  Aug 2021|      Interventional|  Apr 2019|       Dental Caries|                null|             Aug|           2021|\n|NCT02287233|              AbbVie|Completed|Dec 2014|  Aug 2021|      Interventional|  Nov 2014|            Leukemia|Cytarabine,Veneto...|             Aug|           2021|\n|NCT04291066|HonorHealth Resea...|Completed|Sep 2019|  Aug 2021|      Interventional|  Dec 2019|      Brain Injuries|Acetylcysteine,N-...|             Aug|           2021|\n|NCT03825107|Retina Foundation...|Completed|Jan 2019|  Aug 2021|      Interventional|  Jan 2019|           Amblyopia|                null|             Aug|           2021|\n|NCT04727567|       Atrium Health|Completed|Apr 2020|  Aug 2021|       Observational|  Jan 2021|                null|                null|             Aug|           2021|\n|NCT04721392|Vrije Universitei...|Completed|Mar 2021|  Aug 2021|      Interventional|  Sep 2020|Fatigue,Mental Fa...|                null|             Aug|           2021|\n|NCT04723563|    Frederick Health|Completed|Feb 2021|  Aug 2021|      Interventional|  Jan 2021|  COVID-19,Pneumonia|             Heparin|             Aug|           2021|\n|NCT04726098|Manuel Taboada Muñiz|Completed|Jan 2021|  Aug 2021|      Interventional|  Jan 2021|COVID-19,Respirat...|Dexamethasone,Dex...|             Aug|           2021|\n|NCT04720248|Dr. Negrin Univer...|Completed|Feb 2021|  Aug 2021|       Observational|  Jan 2021|                Pain|            Dipyrone|             Aug|           2021|\n|NCT04721847|Riphah Internatio...|Completed|Aug 2020|  Aug 2021|      Interventional|  Jan 2021|Diabetic Neuropat...|                null|             Aug|           2021|\n|NCT04723524|University of Kar...|Completed|Sep 2020|  Aug 2021|      Interventional|  Jan 2021|            COVID-19|                null|             Aug|           2021|\n+-----------+--------------------+---------+--------+----------+--------------------+----------+--------------------+--------------------+----------------+---------------+\nonly showing top 20 rows\n\n+-----------+--------------------+---------+--------+----------+--------------------+----------+--------------------+--------------------+----------------+---------------+\n|         Id|             Sponsor|   Status|   Start|Completion|                Type|Submission|          Conditions|       Interventions|Completion_month|Completion_year|\n+-----------+--------------------+---------+--------+----------+--------------------+----------+--------------------+--------------------+----------------+---------------+\n|NCT03092427|Assistance Publiq...|Completed|Sep 2017|  Sep 2021|      Interventional|  Mar 2017|           Arthritis|                null|             Sep|           2021|\n|NCT03927794|Ain Shams University|Completed|Sep 2020|  Sep 2021|      Interventional|  Apr 2019|                null|                null|             Sep|           2021|\n|NCT03924323|            Allergan|Completed|May 2019|  Sep 2021|      Interventional|  Apr 2019|Disease,Anxiety D...|          Citalopram|             Sep|           2021|\n|NCT03927404|  Indiana University|Completed|Feb 2020|  Sep 2021|      Interventional|  Apr 2019|                null|                null|             Sep|           2021|\n|NCT01458509|Memorial Sloan Ke...|Completed|Oct 2011|  Sep 2021|       Observational|  Oct 2011|Rectal Neoplasms,...|                null|             Sep|           2021|\n|NCT02543281| Larisa Tereshchenko|Completed|Apr 2015|  Sep 2021|      Interventional|  Sep 2015|Cardiomyopathies,...|                null|             Sep|           2021|\n|NCT04295005|Boehringer Ingelheim|Completed|Nov 2020|  Sep 2021|       Observational|  Mar 2020|   Diabetes Mellitus|Sitagliptin Phosp...|             Sep|           2021|\n|NCT04297735|University of Mic...|Completed|Feb 2020|  Sep 2021|      Interventional|  Feb 2020|         Arrhythmias|                null|             Sep|           2021|\n|NCT04297449|Hannover Medical ...|Completed|Jan 2019|  Sep 2021|       Observational|  Mar 2020|Osteochondritis,O...|                null|             Sep|           2021|\n|NCT01189266|National Cancer I...|Completed|Aug 2010|  Sep 2021|      Interventional|  Aug 2010|Glioma,Astrocytom...|          Vorinostat|             Sep|           2021|\n|NCT03821077|Roxall Medicina E...|Completed|Aug 2018|  Sep 2021|       Observational|  Jan 2019|Rhinitis,Conjunct...|                null|             Sep|           2021|\n|NCT04724382|Harvard School of...|Completed|Apr 2019|  Sep 2021|      Interventional|  Jan 2021|                null|                null|             Sep|           2021|\n|NCT04050215|Jonsson Comprehen...|Completed|Apr 2018|  Sep 2021|      Interventional|  Aug 2019|Carcinoma,Prostat...|Edetic Acid,Galli...|             Sep|           2021|\n|NCT04396652|    Tanta University|Completed|Jul 2020|  Sep 2021|      Interventional|  May 2020|                Pain|                null|             Sep|           2021|\n|NCT03996720|Children's Hospit...|Completed|Oct 2018|  Sep 2021|Observational [Pa...|  Jun 2019|      Sepsis,Toxemia|                null|             Sep|           2021|\n|NCT02747407|Wake Forest Unive...|Completed|May 2016|  Sep 2021|       Observational|  Apr 2016|Glioma,Astrocytom...|            Vaccines|             Sep|           2021|\n|NCT02746224|Institut d'Invest...|Completed|Apr 2016|  Sep 2021|      Interventional|  Apr 2016|Colorectal Neopla...|                null|             Sep|           2021|\n|NCT03100968|University of Ala...|Completed|Jun 2015|  Sep 2021|      Interventional|  Mar 2017|                null|                null|             Sep|           2021|\n|NCT03033212|Rush University M...|Completed|Aug 2017|  Sep 2021|      Interventional|  Dec 2016|Spinal Cord Diseases|                null|             Sep|           2021|\n|NCT03610763|University of Mis...|Completed|Aug 2018|  Sep 2021|      Interventional|  Jun 2018|Peripheral Nerve ...|                null|             Sep|           2021|\n+-----------+--------------------+---------+--------+----------+--------------------+----------+--------------------+--------------------+----------------+---------------+\nonly showing top 20 rows\n\n+-----------+--------------------+---------+--------+----------+--------------+----------+--------------------+--------------------+----------------+---------------+\n|         Id|             Sponsor|   Status|   Start|Completion|          Type|Submission|          Conditions|       Interventions|Completion_month|Completion_year|\n+-----------+--------------------+---------+--------+----------+--------------+----------+--------------------+--------------------+----------------+---------------+\n|NCT03096808|Memorial Sloan Ke...|Completed|Mar 2017|  Oct 2021|Interventional|  Mar 2017|Head and Neck Neo...|                null|             Oct|           2021|\n|NCT03097640|Northwestern Univ...|Completed|Nov 2016|  Oct 2021|Interventional|  Mar 2017|                null|                null|             Oct|           2021|\n|NCT02282371|Memorial Sloan Ke...|Completed|Oct 2014|  Oct 2021|Interventional|  Oct 2014| Neoplasms,Carcinoma|           Cetuximab|             Oct|           2021|\n|NCT04296942|National Cancer I...|Completed|May 2021|  Oct 2021|Interventional|  Mar 2020|Breast Neoplasms,...|Trastuzumab,Ado-T...|             Oct|           2021|\n|NCT03828903|   Assiut University|Completed|Mar 2020|  Oct 2021|Interventional|  Jan 2019|    Pleural Effusion|                null|             Oct|           2021|\n|NCT03823521|Swiss Cardio Tech...|Completed|Nov 2018|  Oct 2021|Interventional|  Jan 2019|                null|Cardioplegic Solu...|             Oct|           2021|\n|NCT01904994| Columbia University|Completed|Aug 2013|  Oct 2021|Interventional|  Jul 2013|Acquired Immunode...|Anti-Retroviral A...|             Oct|           2021|\n|NCT04723667|Chinese Universit...|Completed|Sep 2020|  Oct 2021|Interventional|  Dec 2020|Cognitive Dysfunc...|                null|             Oct|           2021|\n|NCT04729192|Konya Meram State...|Completed|Feb 2021|  Oct 2021| Observational|  Jan 2021|                null|                null|             Oct|           2021|\n|NCT04058158|Samsung Bioepis C...|Completed|Aug 2019|  Oct 2021|Interventional|  Aug 2019|      Hemoglobinuria|          Eculizumab|             Oct|           2021|\n|NCT03365193|University Hospit...|Completed|Dec 2017|  Oct 2021| Observational|  Dec 2017|        Endocarditis|                null|             Oct|           2021|\n|NCT03107286|Boston Children's...|Completed|Jan 2018|  Oct 2021|Interventional|  Mar 2017|     Kidney Diseases|                null|             Oct|           2021|\n|NCT03107247|Boston Children's...|Completed|Oct 2017|  Oct 2021|Interventional|  Mar 2017|                null|Technetium Tc 99m...|             Oct|           2021|\n|NCT03107195|Boston Children's...|Completed|Oct 2017|  Oct 2021|Interventional|  Mar 2017|     Kidney Diseases|                null|             Oct|           2021|\n|NCT03938246|Sagimet Bioscienc...|Completed|Mar 2019|  Oct 2021|Interventional|  Apr 2019|Liver Diseases,Fa...|                null|             Oct|           2021|\n|NCT03451422|               Amgen|Completed|Apr 2018|  Oct 2021|Interventional|  Feb 2018| Lupus Erythematosus|                null|             Oct|           2021|\n|NCT01878721|Turku University ...|Completed|Jan 2011|  Oct 2021| Observational|  Jun 2013|Infections,Commun...|                null|             Oct|           2021|\n|NCT01417546|National Cancer I...|Completed|Dec 2011|  Oct 2021|Interventional|  Aug 2011|Neoplasms,Carcino...|                null|             Oct|           2021|\n|NCT02909673|The University of...|Completed|Jan 2018|  Oct 2021|Interventional|  Sep 2016|                null|                null|             Oct|           2021|\n|NCT03282266|Nanjing First Hos...|Completed|Jan 2018|  Oct 2021|Interventional|  Sep 2017|Pulmonary Arteria...|                null|             Oct|           2021|\n+-----------+--------------------+---------+--------+----------+--------------+----------+--------------------+--------------------+----------------+---------------+\nonly showing top 20 rows\n\n+---+-------+------+-----+----------+----+----------+----------+-------------+----------------+---------------+\n| Id|Sponsor|Status|Start|Completion|Type|Submission|Conditions|Interventions|Completion_month|Completion_year|\n+---+-------+------+-----+----------+----+----------+----------+-------------+----------------+---------------+\n+---+-------+------+-----+----------+----+----------+----------+-------------+----------------+---------------+\n\n+---+-------+------+-----+----------+----+----------+----------+-------------+----------------+---------------+\n| Id|Sponsor|Status|Start|Completion|Type|Submission|Conditions|Interventions|Completion_month|Completion_year|\n+---+-------+------+-----+----------+----+----------+----------+-------------+----------------+---------------+\n+---+-------+------+-----+----------+----+----------+----------+-------------+----------------+---------------+\n\n","removedWidgets":[],"addedWidgets":{},"metadata":{},"type":"ansi","arguments":{}}},"output_type":"display_data","data":{"text/plain":["+-----------+--------------------+---------+--------+----------+--------------------+----------+--------------------+--------------------+----------------+---------------+\n|         Id|             Sponsor|   Status|   Start|Completion|                Type|Submission|          Conditions|       Interventions|Completion_month|Completion_year|\n+-----------+--------------------+---------+--------+----------+--------------------+----------+--------------------+--------------------+----------------+---------------+\n|NCT02753530|           Orphazyme|Completed|Aug 2017|  Jan 2021|      Interventional|  Apr 2016|            Myositis|                null|             Jan|           2021|\n|NCT02758782|Charite Universit...|Completed|Sep 2016|  Jan 2021|      Interventional|  Apr 2016|         Spondylitis| Celecoxib,Golimumab|             Jan|           2021|\n|NCT03095209|Fox Chase Cancer ...|Completed|Feb 2017|  Jan 2021|       Observational|  Mar 2017|Lung Neoplasms,Es...|Paclitaxel,Carbop...|             Jan|           2021|\n|NCT03096834|Novartis Pharmace...|Completed|Mar 2017|  Jan 2021|      Interventional|  Mar 2017|  Migraine Disorders|            Erenumab|             Jan|           2021|\n|NCT03090854|Assistance Publiq...|Completed|Nov 2017|  Jan 2021|       Observational|  Feb 2017|   Alzheimer Disease|                null|             Jan|           2021|\n|NCT03922828|Singapore General...|Completed|May 2018|  Jan 2021|Observational [Pa...|  Apr 2019|Lung Neoplasms,Ad...|                null|             Jan|           2021|\n|NCT03922841|Singapore General...|Completed|Mar 2018|  Jan 2021|Observational [Pa...|  Apr 2019|    Pleural Diseases|                null|             Jan|           2021|\n|NCT03923595|   Alessandra Mangia|Completed|Jul 2019|  Jan 2021|       Observational|  Apr 2019|         Hepatitis C|                null|             Jan|           2021|\n|NCT03927846|Wake Forest Unive...|Completed|Jul 2019|  Jan 2021|      Interventional|  Apr 2019|Musculoskeletal Pain|                null|             Jan|           2021|\n|NCT03926845|Institute of Derm...|Completed|Apr 2019|  Jan 2021|      Interventional|  Apr 2019|Hyperpigmentation...|                null|             Jan|           2021|\n|NCT03925779| Menoufia University|Completed|Jun 2019|  Jan 2021|      Interventional|  Apr 2019|                null|Dexmedetomidine,R...|             Jan|           2021|\n|NCT02540681|Major Extremity T...|Completed|Jan 2015|  Jan 2021|       Observational|  Jun 2015|          Amputation|                null|             Jan|           2021|\n|NCT02546531|Washington Univer...|Completed|Feb 2016|  Jan 2021|      Interventional|  Aug 2015|                null|Gemcitabine,Pembr...|             Jan|           2021|\n|NCT02549131|Mednax Center for...|Completed|Sep 2015|  Jan 2021|      Interventional|  Aug 2015|                null|                null|             Jan|           2021|\n|NCT02547493|University Hospit...|Completed|Mar 2016|  Jan 2021|      Interventional|  Sep 2015|           Arthritis|Abatacept,Vaccine...|             Jan|           2021|\n|NCT02547922|         AstraZeneca|Completed|Nov 2015|  Jan 2021|      Interventional|  Aug 2015|Nephritis,Lupus N...|                null|             Jan|           2021|\n|NCT04292301|      SpinTech, Inc.|Completed|Jun 2020|  Jan 2021|      Interventional|  Feb 2020|                null|                null|             Jan|           2021|\n|NCT04296721|Hospital Universi...|Completed|Jan 2019|  Jan 2021|      Interventional|  Mar 2020|Apnea,Sleep Apnea...|                null|             Jan|           2021|\n|NCT04291339|   Yonsei University|Completed|Nov 2020|  Jan 2021|      Interventional|  Feb 2020|                null|                null|             Jan|           2021|\n|NCT04295876|University of Cal...|Completed|Dec 2019|  Jan 2021|      Interventional|  Mar 2020|Acquired Immunode...|                null|             Jan|           2021|\n+-----------+--------------------+---------+--------+----------+--------------------+----------+--------------------+--------------------+----------------+---------------+\nonly showing top 20 rows\n\n+-----------+--------------------+---------+--------+----------+--------------+----------+--------------------+--------------------+----------------+---------------+\n|         Id|             Sponsor|   Status|   Start|Completion|          Type|Submission|          Conditions|       Interventions|Completion_month|Completion_year|\n+-----------+--------------------+---------+--------+----------+--------------+----------+--------------------+--------------------+----------------+---------------+\n|NCT02759575|       Vinita Takiar|Completed|Apr 2016|  Feb 2021|Interventional|  Apr 2016|Carcinoma,Squamou...|       Pembrolizumab|             Feb|           2021|\n|NCT02758626|  NYU Langone Health|Completed|Nov 2016|  Feb 2021|Interventional|  Apr 2016| Epilepsy,Epilepsies|                null|             Feb|           2021|\n|NCT02750670|University Health...|Completed|Mar 2017|  Feb 2021|Interventional|  Apr 2016|            Lymphoma|Gemcitabine,Dexam...|             Feb|           2021|\n|NCT03093480|Bioverativ, a San...|Completed|Dec 2017|  Feb 2021|Interventional|  Mar 2017|        Hemophilia A|         Factor VIII|             Feb|           2021|\n|NCT03092505|National Institut...|Completed|Jun 2018|  Feb 2021| Observational|  Mar 2017|                null|                null|             Feb|           2021|\n|NCT03926442|Clinical Nutritio...|Completed|Apr 2019|  Feb 2021|Interventional|  Apr 2019|                null|                null|             Feb|           2021|\n|NCT03929263|Oklahoma State Un...|Completed|Sep 2019|  Feb 2021|Interventional|  Apr 2019|                null|                null|             Feb|           2021|\n|NCT01455831|Ottawa Hospital R...|Completed|Sep 2011|  Feb 2021|Interventional|  Oct 2011|Colorectal Neopla...|Tinzaparin,Hepari...|             Feb|           2021|\n|NCT01827501|Technische Univer...|Completed|Apr 2013|  Feb 2021|Interventional|  Apr 2013|            Delirium|                null|             Feb|           2021|\n|NCT02545049|               Bayer|Completed|Sep 2015|  Feb 2021|Interventional|  Sep 2015|Kidney Diseases,D...|                null|             Feb|           2021|\n|NCT04297644|     Intelomed, Inc.|Completed|Nov 2020|  Feb 2021| Observational|  Mar 2020|                null|                null|             Feb|           2021|\n|NCT04296201|        Lumenis Ltd.|Completed|Sep 2020|  Feb 2021|Interventional|  Mar 2020|         Contracture|                null|             Feb|           2021|\n|NCT04297072|               Bayer|Completed|May 2020|  Feb 2021| Observational|  Mar 2020| Atrial Fibrillation|         Rivaroxaban|             Feb|           2021|\n|NCT04297007|  Medipol University|Completed|Mar 2020|  Feb 2021|Interventional|  Feb 2020|Breast Neoplasms,...|                null|             Feb|           2021|\n|NCT00579631|Memorial Sloan Ke...|Completed|Jun 2004|  Feb 2021| Observational|  Dec 2007|                null|                null|             Feb|           2021|\n|NCT03824860|Dana-Farber Cance...|Completed|Aug 2019|  Feb 2021|Interventional|  Jan 2019|Peripheral Nervou...|                null|             Feb|           2021|\n|NCT03828669| Stanford University|Completed|Jan 2019|  Feb 2021| Observational|  Jan 2019|                Pain|                null|             Feb|           2021|\n|NCT03820284|   Assiut University|Completed|Feb 2019|  Feb 2021| Observational|  Jan 2019|Helicobacter Infe...|                null|             Feb|           2021|\n|NCT03825380|   Laboratoires Thea|Completed|Nov 2018|  Feb 2021|Interventional|  Jan 2019| Ocular Hypertension|         Bimatoprost|             Feb|           2021|\n|NCT01901289|Cook Research Inc...|Completed|Aug 2013|  Feb 2021|Interventional|  Jul 2013|Peripheral Arteri...|                null|             Feb|           2021|\n+-----------+--------------------+---------+--------+----------+--------------+----------+--------------------+--------------------+----------------+---------------+\nonly showing top 20 rows\n\n+-----------+--------------------+---------+--------+----------+--------------------+----------+--------------------+--------------------+----------------+---------------+\n|         Id|             Sponsor|   Status|   Start|Completion|                Type|Submission|          Conditions|       Interventions|Completion_month|Completion_year|\n+-----------+--------------------+---------+--------+----------+--------------------+----------+--------------------+--------------------+----------------+---------------+\n|NCT02754778|Martin-Luther-Uni...|Completed|Apr 2016|  Mar 2021|      Interventional|  Apr 2016|Pre-Eclampsia,HEL...|                null|             Mar|           2021|\n|NCT02753309|The University of...|Completed|Jun 2016|  Mar 2021|      Interventional|  Apr 2016|Urinary Bladder N...|           Sirolimus|             Mar|           2021|\n|NCT03094247|Washington Univer...|Completed|Oct 2017|  Mar 2021|      Interventional|  Mar 2017|Malnutrition,Seve...|         Amoxicillin|             Mar|           2021|\n|NCT03924752|Georgia Institute...|Completed|Aug 2019|  Mar 2021|      Interventional|  Apr 2019|        Leg Injuries|                null|             Mar|           2021|\n|NCT03920046|TC Erciyes Univer...|Completed|Jan 2019|  Mar 2021|Observational [Pa...|  Apr 2019|Intestinal Diseas...|                null|             Mar|           2021|\n|NCT03928925|Vanderbilt Univer...|Completed|Apr 2019|  Mar 2021|      Interventional|  Apr 2019|Respiratory Insuf...|                null|             Mar|           2021|\n|NCT03924843|University Medica...|Completed|Nov 2017|  Mar 2021|       Observational|  Mar 2019|                null|                null|             Mar|           2021|\n|NCT03928821|National Institut...|Completed|Jul 2019|  Mar 2021|      Interventional|  Apr 2019|      HIV Infections|                null|             Mar|           2021|\n|NCT03927313|University of Cap...|Completed|Jun 2019|  Mar 2021|      Interventional|  Mar 2019|Tuberculosis,Meni...|Aspirin,Rifampin,...|             Mar|           2021|\n|NCT03922867|         Mayo Clinic|Completed|Dec 2019|  Mar 2021|      Interventional|  Apr 2019|Fibromyalgia,Myof...|                null|             Mar|           2021|\n|NCT03924427|Bristol-Myers Squibb|Completed|Apr 2019|  Mar 2021|      Interventional|  Apr 2019|           Psoriasis|          BMS-986165|             Mar|           2021|\n|NCT02287740|Oregon Research I...|Completed|Nov 2014|  Mar 2021|      Interventional|  Oct 2014|                null|                null|             Mar|           2021|\n|NCT01824290|Eli Lilly and Com...|Completed|Feb 2014|  Mar 2021|      Interventional|  Apr 2013|Pulmonary Arteria...|           Tadalafil|             Mar|           2021|\n|NCT02546674|Novartis Pharmace...|Completed|Feb 2016|  Mar 2021|      Interventional|  Sep 2015|            Leukemia|                null|             Mar|           2021|\n|NCT04298164|University Colleg...|Completed|Nov 2019|  Mar 2021|      Interventional|  Feb 2020|Autistic Disorder...|                null|             Mar|           2021|\n|NCT04291547|  University of York|Completed|Jun 2020|  Mar 2021|      Interventional|  Feb 2020|Depression,Depres...|                null|             Mar|           2021|\n|NCT04294147|Eli Lilly and Com...|Completed|Oct 2020|  Mar 2021|      Interventional|  Mar 2020|  Migraine Disorders|            Erenumab|             Mar|           2021|\n|NCT04299672|Universidad Anton...|Completed|Mar 2020|  Mar 2021|      Interventional|  Nov 2019|                null|                null|             Mar|           2021|\n|NCT04292626|Tomsk National Re...|Completed|Jan 2020|  Mar 2021|      Interventional|  Feb 2020|Lymphoma,Hodgkin ...|                null|             Mar|           2021|\n|NCT00578994|Biomet Orthopedic...|Completed|Mar 2006|  Mar 2021|       Observational|  Dec 2007|            Necrosis|                null|             Mar|           2021|\n+-----------+--------------------+---------+--------+----------+--------------------+----------+--------------------+--------------------+----------------+---------------+\nonly showing top 20 rows\n\n+---+-------+------+-----+----------+----+----------+----------+-------------+----------------+---------------+\n| Id|Sponsor|Status|Start|Completion|Type|Submission|Conditions|Interventions|Completion_month|Completion_year|\n+---+-------+------+-----+----------+----+----------+----------+-------------+----------------+---------------+\n+---+-------+------+-----+----------+----+----------+----------+-------------+----------------+---------------+\n\n+-----------+--------------------+---------+--------+----------+--------------+----------+--------------------+--------------------+----------------+---------------+\n|         Id|             Sponsor|   Status|   Start|Completion|          Type|Submission|          Conditions|       Interventions|Completion_month|Completion_year|\n+-----------+--------------------+---------+--------+----------+--------------+----------+--------------------+--------------------+----------------+---------------+\n|NCT02751151|Inova Health Care...|Completed|Feb 2016|  May 2021|Interventional|  Mar 2016|      Skin Neoplasms| Aminolevulinic Acid|             May|           2021|\n|NCT02755402|Centre hospitalie...|Completed|Jan 2017|  May 2021|Interventional|  Apr 2016|         Hepatitis C|                null|             May|           2021|\n|NCT02750215|Massachusetts Gen...|Completed|May 2016|  May 2021|Interventional|  Apr 2016|      Lung Neoplasms|                null|             May|           2021|\n|NCT02757443|Meshalkin Researc...|Completed|Jun 2016|  May 2021|Interventional|  Apr 2016|                null|Phosphocreatine,A...|             May|           2021|\n|NCT02757313|     Yale University|Completed|Oct 2016|  May 2021|Interventional|  Apr 2016|     Marijuana Abuse|          Dronabinol|             May|           2021|\n|NCT02753127|Sumitomo Dainippo...|Completed|Jun 2016|  May 2021|Interventional|  Apr 2016|Colorectal Neoplasms|Leucovorin,Bevaci...|             May|           2021|\n|NCT03093038|       JointResearch|Completed|May 2014|  May 2021|Interventional|  Dec 2014|      Osteoarthritis|                null|             May|           2021|\n|NCT03926793|GB002, Inc., a wh...|Completed|Feb 2020|  May 2021|Interventional|  Apr 2019|Pulmonary Arteria...|                null|             May|           2021|\n|NCT03925337|Beth Israel Deaco...|Completed|May 2019|  May 2021|Interventional|  Apr 2019|Adenomatous Polyp...|                null|             May|           2021|\n|NCT03921424|Merck Sharp & Doh...|Completed|Nov 2019|  May 2021|Interventional|  Apr 2019|Acquired Immunode...|Heptavalent Pneum...|             May|           2021|\n|NCT03925571|Nantes University...|Completed|May 2019|  May 2021|Interventional|  Apr 2019|Sensation Disorde...|                null|             May|           2021|\n|NCT03920397|Universidade Fede...|Completed|Mar 2015|  May 2021|Interventional|  Apr 2019|   Diabetes Mellitus|     Cholecalciferol|             May|           2021|\n|NCT02283775|              Sanofi|Completed|May 2015|  May 2021|Interventional|  Nov 2014|Multiple Myeloma,...|Dexamethasone,Pom...|             May|           2021|\n|NCT01455818|Ottawa Hospital R...|Completed|Mar 2011|  May 2021| Observational|  Oct 2011|Pulmonary Embolis...|                null|             May|           2021|\n|NCT01826877|Jonsson Comprehen...|Completed|Jan 2013|  May 2021|Interventional|  Apr 2013|           Carcinoma|                null|             May|           2021|\n|NCT02541916|University of Tor...|Completed|Apr 2015|  May 2021|Interventional|  Sep 2015|                null|                null|             May|           2021|\n|NCT02543944|University of Ark...|Completed|Feb 2016|  May 2021|Interventional|  Aug 2015|Opioid-Related Di...|Clonidine,Naltrex...|             May|           2021|\n|NCT02544711|Nantes University...|Completed|Dec 2015|  May 2021|Interventional|  Aug 2015|      Bone Neoplasms|                null|             May|           2021|\n|NCT00924937|Hospital Universi...|Completed|Nov 2009|  May 2021|Interventional|  Jun 2009|Myocardial Infarc...|                null|             May|           2021|\n|NCT04294680|     Campbell Clinic|Completed|Aug 2019|  May 2021|Interventional|  Feb 2020|                null|                null|             May|           2021|\n+-----------+--------------------+---------+--------+----------+--------------+----------+--------------------+--------------------+----------------+---------------+\nonly showing top 20 rows\n\n+-----------+--------------------+---------+--------+----------+--------------+----------+--------------------+--------------------+----------------+---------------+\n|         Id|             Sponsor|   Status|   Start|Completion|          Type|Submission|          Conditions|       Interventions|Completion_month|Completion_year|\n+-----------+--------------------+---------+--------+----------+--------------+----------+--------------------+--------------------+----------------+---------------+\n|NCT02758704|St. Justine's Hos...|Completed|Oct 2015|  Jun 2021|Interventional|  Apr 2016|                null|                null|             Jun|           2021|\n|NCT03092713|Oslo University H...|Completed|Jan 2017|  Jun 2021|Interventional|  Mar 2017|      Brain Injuries|                null|             Jun|           2021|\n|NCT03928028|Children's Hospit...|Completed|Apr 2019|  Jun 2021|Interventional|  Apr 2019|Anorexia,Anorexia...|                null|             Jun|           2021|\n|NCT03924089|Fundación Pública...|Completed|Apr 2019|  Jun 2021|Interventional|  Apr 2019|Kidney Failure,Ma...|                null|             Jun|           2021|\n|NCT03924011|  Hasselt University|Completed|Jul 2020|  Jun 2021|Interventional|  Mar 2019|Breast Neoplasms,...|                null|             Jun|           2021|\n|NCT01822509|National Cancer I...|Completed|May 2013|  Jun 2021|Interventional|  Apr 2013|Lymphoma,Leukemia...|Nivolumab,Ipilimumab|             Jun|           2021|\n|NCT01820611|       Zimmer Biomet|Completed|Feb 2013|  Jun 2021| Observational|  Mar 2013|            Necrosis|                null|             Jun|           2021|\n|NCT02540148|The Eye Machine C...|Completed|Nov 2019|  Jun 2021|Interventional|  Sep 2015|Macular Degeneration|                null|             Jun|           2021|\n|NCT02544373|University of Mic...|Completed|Nov 2015|  Jun 2021|Interventional|  May 2015|Multiple Sclerosi...|                null|             Jun|           2021|\n|NCT02542007|          OrbusNeich|Completed|May 2015|  Jun 2021|Interventional|  Sep 2015|Arteriosclerosis,...|           Sirolimus|             Jun|           2021|\n|NCT02542839|University of Flo...|Completed|Nov 2015|  Jun 2021|Interventional|  Jun 2015|Dystonia,Dystonic...|    Botulinum Toxins|             Jun|           2021|\n|NCT02544750|     GW Research Ltd|Completed|Aug 2016|  Jun 2021|Interventional|  Sep 2015|Tuberous Sclerosi...|         Cannabidiol|             Jun|           2021|\n|NCT02544880|Donald T. Weed, M...|Completed|Apr 2016|  Jun 2021|Interventional|  Sep 2015|Carcinoma,Squamou...|  Tadalafil,Vaccines|             Jun|           2021|\n|NCT04298749|      Genexine, Inc.|Completed|Aug 2020|  Jun 2021|Interventional|  Feb 2020| Autoimmune Diseases|                null|             Jun|           2021|\n|NCT04292938| IRCCS Eugenio Medea|Completed|Mar 2019|  Jun 2021|Interventional|  Feb 2020|Glycogen Storage ...|                null|             Jun|           2021|\n|NCT04295200|Louisiana State U...|Completed|Dec 2019|  Jun 2021|Interventional|  Feb 2020|                null|                null|             Jun|           2021|\n|NCT04290910|University of Man...|Completed|Jan 2019|  Jun 2021|Interventional|  Feb 2020|         Weight Loss|                null|             Jun|           2021|\n|NCT04298931|University of Aarhus|Completed|May 2020|  Jun 2021| Observational|  Mar 2020|         Hypovolemia|                null|             Jun|           2021|\n|NCT01912820|Jonsson Comprehen...|Completed|Jan 2014|  Jun 2021|Interventional|  Jul 2013| Prostatic Neoplasms|           Quercetin|             Jun|           2021|\n|NCT01911585|University of Pen...|Completed|Sep 2013|  Jun 2021|Interventional|  Jul 2013|    Stress Disorders|                null|             Jun|           2021|\n+-----------+--------------------+---------+--------+----------+--------------+----------+--------------------+--------------------+----------------+---------------+\nonly showing top 20 rows\n\n+-----------+--------------------+---------+--------+----------+--------------+----------+--------------------+--------------------+----------------+---------------+\n|         Id|             Sponsor|   Status|   Start|Completion|          Type|Submission|          Conditions|       Interventions|Completion_month|Completion_year|\n+-----------+--------------------+---------+--------+----------+--------------+----------+--------------------+--------------------+----------------+---------------+\n|NCT03092063|University of Cal...|Completed|Mar 2017|  Jul 2021|Interventional|  Mar 2017|   Diabetes Mellitus|                null|             Jul|           2021|\n|NCT03093402|National Institut...|Completed|Dec 2017|  Jul 2021|Interventional|  Feb 2017| Lupus Erythematosus|           Lenabasum|             Jul|           2021|\n|NCT03928379|Eli Lilly and Com...|Completed|Oct 2019|  Jul 2021|Interventional|  Apr 2019|   Diabetes Mellitus|                null|             Jul|           2021|\n|NCT03922386|       MicroPort CRM|Completed|Sep 2019|  Jul 2021|Interventional|  Apr 2019|         Bradycardia|                null|             Jul|           2021|\n|NCT01454102|Bristol-Myers Squibb|Completed|Dec 2011|  Jul 2021|Interventional|  Sep 2011|Lung Neoplasms,Ca...|Gemcitabine,Pacli...|             Jul|           2021|\n|NCT02546921|  Cancer Research UK|Completed|Sep 2015|  Jul 2021|Interventional|  Aug 2015|                null|                null|             Jul|           2021|\n|NCT04293497|Gangnam Severance...|Completed|Feb 2020|  Jul 2021|Interventional|  Feb 2020|Pancreatic Neoplasms|                null|             Jul|           2021|\n|NCT04295642|Cerevel Therapeut...|Completed|Jan 2020|  Jul 2021|Interventional|  Jan 2020|   Parkinson Disease|                null|             Jul|           2021|\n|NCT04296032|Taipei Medical Un...|Completed|May 2020|  Jul 2021|Interventional|  Mar 2020|              Stroke|                null|             Jul|           2021|\n|NCT04299165|Kaia Health Software|Completed|Aug 2019|  Jul 2021|Interventional|  Feb 2020|Lung Diseases,Pul...|                null|             Jul|           2021|\n|NCT04291365|Albany Medical Co...|Completed|Mar 2020|  Jul 2021|Interventional|  Feb 2020|                null|                null|             Jul|           2021|\n|NCT04297774|Taipei Medical Un...|Completed|May 2020|  Jul 2021|Interventional|  Mar 2020|              Stroke|                null|             Jul|           2021|\n|NCT00575809|The University of...|Completed|May 2005|  Jul 2021| Observational|  Dec 2007|Mucositis,Stomatitis|                null|             Jul|           2021|\n|NCT00570804|M.D. Anderson Can...|Completed|Dec 2007|  Jul 2021|Interventional|  Dec 2007|    Alcohol Drinking|                null|             Jul|           2021|\n|NCT03821090|   Assiut University|Completed|Jul 2019|  Jul 2021| Observational|  Jan 2019|Arthritis,Atheros...|                null|             Jul|           2021|\n|NCT03822728|Samsung Medical C...|Completed|Aug 2017|  Jul 2021|Interventional|  Jan 2019|Parotid Neoplasms...|                null|             Jul|           2021|\n|NCT04729257|Philips Electroni...|Completed|Mar 2021|  Jul 2021|Interventional|  Jan 2021|                null|                null|             Jul|           2021|\n|NCT04725955|Harokopio University|Completed|Jan 2021|  Jul 2021|Interventional|  Jan 2021|                null|                null|             Jul|           2021|\n|NCT03505099|Novartis Gene The...|Completed|Apr 2018|  Jul 2021|Interventional|  Apr 2018|Muscular Atrophy,...|                null|             Jul|           2021|\n|NCT03501862|The Hong Kong Pol...|Completed|Jan 2017|  Jul 2021|Interventional|  Mar 2018|Psychotic Disorde...|                null|             Jul|           2021|\n+-----------+--------------------+---------+--------+----------+--------------+----------+--------------------+--------------------+----------------+---------------+\nonly showing top 20 rows\n\n+-----------+--------------------+---------+--------+----------+--------------------+----------+--------------------+--------------------+----------------+---------------+\n|         Id|             Sponsor|   Status|   Start|Completion|                Type|Submission|          Conditions|       Interventions|Completion_month|Completion_year|\n+-----------+--------------------+---------+--------+----------+--------------------+----------+--------------------+--------------------+----------------+---------------+\n|NCT02758574|University of Pit...|Completed|May 2016|  Aug 2021|      Interventional|  Mar 2016|Pulmonary Embolis...|                null|             Aug|           2021|\n|NCT03091764|University of Sydney|Completed|Jul 2016|  Aug 2021|Observational [Pa...|  Mar 2017|Urinary Bladder N...|                null|             Aug|           2021|\n|NCT03093779|University of Mic...|Completed|Dec 2016|  Aug 2021|       Observational|  Mar 2017|Hearing Loss,Deaf...|                null|             Aug|           2021|\n|NCT03929562|University of Mic...|Completed|Aug 2019|  Aug 2021|      Interventional|  Apr 2019|    Alcohol Drinking|                null|             Aug|           2021|\n|NCT03926169|              AbbVie|Completed|Jun 2019|  Aug 2021|      Interventional|  Apr 2019|Hidradenitis Supp...|          Antibodies|             Aug|           2021|\n|NCT03925805|    University Ghent|Completed|Nov 2019|  Aug 2021|       Observational|  Apr 2019|Musculoskeletal D...|                null|             Aug|           2021|\n|NCT03928184|Biosplice Therape...|Completed|May 2019|  Aug 2021|      Interventional|  Apr 2019|      Osteoarthritis|        Lorecivivint|             Aug|           2021|\n|NCT03920527|Postgraduate Inst...|Completed|Jul 2019|  Aug 2021|      Interventional|  Apr 2019|Aspergillosis,Pul...|        Itraconazole|             Aug|           2021|\n|NCT03929809|  University of Iowa|Completed|Jun 2019|  Aug 2021|       Observational|  Apr 2019|Hearing Loss,Deaf...|                null|             Aug|           2021|\n|NCT03923192|    Cairo University|Completed|May 2020|  Aug 2021|      Interventional|  Apr 2019|       Dental Caries|                null|             Aug|           2021|\n|NCT02287233|              AbbVie|Completed|Dec 2014|  Aug 2021|      Interventional|  Nov 2014|            Leukemia|Cytarabine,Veneto...|             Aug|           2021|\n|NCT04291066|HonorHealth Resea...|Completed|Sep 2019|  Aug 2021|      Interventional|  Dec 2019|      Brain Injuries|Acetylcysteine,N-...|             Aug|           2021|\n|NCT03825107|Retina Foundation...|Completed|Jan 2019|  Aug 2021|      Interventional|  Jan 2019|           Amblyopia|                null|             Aug|           2021|\n|NCT04727567|       Atrium Health|Completed|Apr 2020|  Aug 2021|       Observational|  Jan 2021|                null|                null|             Aug|           2021|\n|NCT04721392|Vrije Universitei...|Completed|Mar 2021|  Aug 2021|      Interventional|  Sep 2020|Fatigue,Mental Fa...|                null|             Aug|           2021|\n|NCT04723563|    Frederick Health|Completed|Feb 2021|  Aug 2021|      Interventional|  Jan 2021|  COVID-19,Pneumonia|             Heparin|             Aug|           2021|\n|NCT04726098|Manuel Taboada Muñiz|Completed|Jan 2021|  Aug 2021|      Interventional|  Jan 2021|COVID-19,Respirat...|Dexamethasone,Dex...|             Aug|           2021|\n|NCT04720248|Dr. Negrin Univer...|Completed|Feb 2021|  Aug 2021|       Observational|  Jan 2021|                Pain|            Dipyrone|             Aug|           2021|\n|NCT04721847|Riphah Internatio...|Completed|Aug 2020|  Aug 2021|      Interventional|  Jan 2021|Diabetic Neuropat...|                null|             Aug|           2021|\n|NCT04723524|University of Kar...|Completed|Sep 2020|  Aug 2021|      Interventional|  Jan 2021|            COVID-19|                null|             Aug|           2021|\n+-----------+--------------------+---------+--------+----------+--------------------+----------+--------------------+--------------------+----------------+---------------+\nonly showing top 20 rows\n\n+-----------+--------------------+---------+--------+----------+--------------------+----------+--------------------+--------------------+----------------+---------------+\n|         Id|             Sponsor|   Status|   Start|Completion|                Type|Submission|          Conditions|       Interventions|Completion_month|Completion_year|\n+-----------+--------------------+---------+--------+----------+--------------------+----------+--------------------+--------------------+----------------+---------------+\n|NCT03092427|Assistance Publiq...|Completed|Sep 2017|  Sep 2021|      Interventional|  Mar 2017|           Arthritis|                null|             Sep|           2021|\n|NCT03927794|Ain Shams University|Completed|Sep 2020|  Sep 2021|      Interventional|  Apr 2019|                null|                null|             Sep|           2021|\n|NCT03924323|            Allergan|Completed|May 2019|  Sep 2021|      Interventional|  Apr 2019|Disease,Anxiety D...|          Citalopram|             Sep|           2021|\n|NCT03927404|  Indiana University|Completed|Feb 2020|  Sep 2021|      Interventional|  Apr 2019|                null|                null|             Sep|           2021|\n|NCT01458509|Memorial Sloan Ke...|Completed|Oct 2011|  Sep 2021|       Observational|  Oct 2011|Rectal Neoplasms,...|                null|             Sep|           2021|\n|NCT02543281| Larisa Tereshchenko|Completed|Apr 2015|  Sep 2021|      Interventional|  Sep 2015|Cardiomyopathies,...|                null|             Sep|           2021|\n|NCT04295005|Boehringer Ingelheim|Completed|Nov 2020|  Sep 2021|       Observational|  Mar 2020|   Diabetes Mellitus|Sitagliptin Phosp...|             Sep|           2021|\n|NCT04297735|University of Mic...|Completed|Feb 2020|  Sep 2021|      Interventional|  Feb 2020|         Arrhythmias|                null|             Sep|           2021|\n|NCT04297449|Hannover Medical ...|Completed|Jan 2019|  Sep 2021|       Observational|  Mar 2020|Osteochondritis,O...|                null|             Sep|           2021|\n|NCT01189266|National Cancer I...|Completed|Aug 2010|  Sep 2021|      Interventional|  Aug 2010|Glioma,Astrocytom...|          Vorinostat|             Sep|           2021|\n|NCT03821077|Roxall Medicina E...|Completed|Aug 2018|  Sep 2021|       Observational|  Jan 2019|Rhinitis,Conjunct...|                null|             Sep|           2021|\n|NCT04724382|Harvard School of...|Completed|Apr 2019|  Sep 2021|      Interventional|  Jan 2021|                null|                null|             Sep|           2021|\n|NCT04050215|Jonsson Comprehen...|Completed|Apr 2018|  Sep 2021|      Interventional|  Aug 2019|Carcinoma,Prostat...|Edetic Acid,Galli...|             Sep|           2021|\n|NCT04396652|    Tanta University|Completed|Jul 2020|  Sep 2021|      Interventional|  May 2020|                Pain|                null|             Sep|           2021|\n|NCT03996720|Children's Hospit...|Completed|Oct 2018|  Sep 2021|Observational [Pa...|  Jun 2019|      Sepsis,Toxemia|                null|             Sep|           2021|\n|NCT02747407|Wake Forest Unive...|Completed|May 2016|  Sep 2021|       Observational|  Apr 2016|Glioma,Astrocytom...|            Vaccines|             Sep|           2021|\n|NCT02746224|Institut d'Invest...|Completed|Apr 2016|  Sep 2021|      Interventional|  Apr 2016|Colorectal Neopla...|                null|             Sep|           2021|\n|NCT03100968|University of Ala...|Completed|Jun 2015|  Sep 2021|      Interventional|  Mar 2017|                null|                null|             Sep|           2021|\n|NCT03033212|Rush University M...|Completed|Aug 2017|  Sep 2021|      Interventional|  Dec 2016|Spinal Cord Diseases|                null|             Sep|           2021|\n|NCT03610763|University of Mis...|Completed|Aug 2018|  Sep 2021|      Interventional|  Jun 2018|Peripheral Nerve ...|                null|             Sep|           2021|\n+-----------+--------------------+---------+--------+----------+--------------------+----------+--------------------+--------------------+----------------+---------------+\nonly showing top 20 rows\n\n+-----------+--------------------+---------+--------+----------+--------------+----------+--------------------+--------------------+----------------+---------------+\n|         Id|             Sponsor|   Status|   Start|Completion|          Type|Submission|          Conditions|       Interventions|Completion_month|Completion_year|\n+-----------+--------------------+---------+--------+----------+--------------+----------+--------------------+--------------------+----------------+---------------+\n|NCT03096808|Memorial Sloan Ke...|Completed|Mar 2017|  Oct 2021|Interventional|  Mar 2017|Head and Neck Neo...|                null|             Oct|           2021|\n|NCT03097640|Northwestern Univ...|Completed|Nov 2016|  Oct 2021|Interventional|  Mar 2017|                null|                null|             Oct|           2021|\n|NCT02282371|Memorial Sloan Ke...|Completed|Oct 2014|  Oct 2021|Interventional|  Oct 2014| Neoplasms,Carcinoma|           Cetuximab|             Oct|           2021|\n|NCT04296942|National Cancer I...|Completed|May 2021|  Oct 2021|Interventional|  Mar 2020|Breast Neoplasms,...|Trastuzumab,Ado-T...|             Oct|           2021|\n|NCT03828903|   Assiut University|Completed|Mar 2020|  Oct 2021|Interventional|  Jan 2019|    Pleural Effusion|                null|             Oct|           2021|\n|NCT03823521|Swiss Cardio Tech...|Completed|Nov 2018|  Oct 2021|Interventional|  Jan 2019|                null|Cardioplegic Solu...|             Oct|           2021|\n|NCT01904994| Columbia University|Completed|Aug 2013|  Oct 2021|Interventional|  Jul 2013|Acquired Immunode...|Anti-Retroviral A...|             Oct|           2021|\n|NCT04723667|Chinese Universit...|Completed|Sep 2020|  Oct 2021|Interventional|  Dec 2020|Cognitive Dysfunc...|                null|             Oct|           2021|\n|NCT04729192|Konya Meram State...|Completed|Feb 2021|  Oct 2021| Observational|  Jan 2021|                null|                null|             Oct|           2021|\n|NCT04058158|Samsung Bioepis C...|Completed|Aug 2019|  Oct 2021|Interventional|  Aug 2019|      Hemoglobinuria|          Eculizumab|             Oct|           2021|\n|NCT03365193|University Hospit...|Completed|Dec 2017|  Oct 2021| Observational|  Dec 2017|        Endocarditis|                null|             Oct|           2021|\n|NCT03107286|Boston Children's...|Completed|Jan 2018|  Oct 2021|Interventional|  Mar 2017|     Kidney Diseases|                null|             Oct|           2021|\n|NCT03107247|Boston Children's...|Completed|Oct 2017|  Oct 2021|Interventional|  Mar 2017|                null|Technetium Tc 99m...|             Oct|           2021|\n|NCT03107195|Boston Children's...|Completed|Oct 2017|  Oct 2021|Interventional|  Mar 2017|     Kidney Diseases|                null|             Oct|           2021|\n|NCT03938246|Sagimet Bioscienc...|Completed|Mar 2019|  Oct 2021|Interventional|  Apr 2019|Liver Diseases,Fa...|                null|             Oct|           2021|\n|NCT03451422|               Amgen|Completed|Apr 2018|  Oct 2021|Interventional|  Feb 2018| Lupus Erythematosus|                null|             Oct|           2021|\n|NCT01878721|Turku University ...|Completed|Jan 2011|  Oct 2021| Observational|  Jun 2013|Infections,Commun...|                null|             Oct|           2021|\n|NCT01417546|National Cancer I...|Completed|Dec 2011|  Oct 2021|Interventional|  Aug 2011|Neoplasms,Carcino...|                null|             Oct|           2021|\n|NCT02909673|The University of...|Completed|Jan 2018|  Oct 2021|Interventional|  Sep 2016|                null|                null|             Oct|           2021|\n|NCT03282266|Nanjing First Hos...|Completed|Jan 2018|  Oct 2021|Interventional|  Sep 2017|Pulmonary Arteria...|                null|             Oct|           2021|\n+-----------+--------------------+---------+--------+----------+--------------+----------+--------------------+--------------------+----------------+---------------+\nonly showing top 20 rows\n\n+---+-------+------+-----+----------+----+----------+----------+-------------+----------------+---------------+\n| Id|Sponsor|Status|Start|Completion|Type|Submission|Conditions|Interventions|Completion_month|Completion_year|\n+---+-------+------+-----+----------+----+----------+----------+-------------+----------------+---------------+\n+---+-------+------+-----+----------+----+----------+----------+-------------+----------------+---------------+\n\n+---+-------+------+-----+----------+----+----------+----------+-------------+----------------+---------------+\n| Id|Sponsor|Status|Start|Completion|Type|Submission|Conditions|Interventions|Completion_month|Completion_year|\n+---+-------+------+-----+----------+----+----------+----------+-------------+----------------+---------------+\n+---+-------+------+-----+----------+----+----------+----------+-------------+----------------+---------------+\n\n"]}}],"execution_count":0},{"cell_type":"code","source":[""],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"dfc1d66e-49d6-48ba-9fe5-b96806efc507"}},"outputs":[],"execution_count":0}],"metadata":{"application/vnd.databricks.v1+notebook":{"notebookName":"alex_df","dashboards":[],"notebookMetadata":{"pythonIndentUnit":4},"language":"python","widgets":{},"notebookOrigID":2603982437103268}},"nbformat":4,"nbformat_minor":0}
